{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import requests\n",
    "import bs4  # BeautifulSoup is part of bs4 package\n",
    "import pandas as pd\n",
    "import re\n",
    "import plotly\n",
    "import IPython"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Python Version: 3.12.2 | packaged by conda-forge | (main, Feb 16 2024, 20:54:21) [Clang 16.0.6 ]\n",
      "Requests Version: 2.32.2\n",
      "BeautifulSoup Version: 4.12.3\n",
      "Pandas Version: 2.2.2\n",
      "Plotly Version: 5.22.0\n",
      "IPython Version: 8.25.0\n"
     ]
    }
   ],
   "source": [
    "# Print Python version\n",
    "print(f\"Python Version: {sys.version}\")\n",
    "\n",
    "# Print library versions\n",
    "print(f\"Requests Version: {requests.__version__}\")\n",
    "print(f\"BeautifulSoup Version: {bs4.__version__}\")\n",
    "print(f\"Pandas Version: {pd.__version__}\")\n",
    "print(f\"Plotly Version: {plotly.__version__}\")\n",
    "print(f\"IPython Version: {IPython.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Country</th>\n",
       "      <th>Entry Requirements</th>\n",
       "      <th>CDC Recommendations</th>\n",
       "      <th>Transmission Areas</th>\n",
       "      <th>Drug Resistance</th>\n",
       "      <th>Species</th>\n",
       "      <th>Recommended Chemoprophylaxis</th>\n",
       "      <th>Last Updated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Afghanistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas &lt;2,500 m (≈8,200 ft) elevation (Apri...</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Albania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving fr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Algeria</td>\n",
       "      <td>Required for travelers ≥9 months old arriving ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>American Samoa  (US)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Andorra</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Angola</td>\n",
       "      <td>Required for arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale...</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Anguilla (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Antarctica</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Antigua and Barbuda</td>\n",
       "      <td>Required for travelers ≥1 year old arriving fr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Argentina</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                Country                                 Entry Requirements  \\\n",
       "0           Afghanistan                                               None   \n",
       "1               Albania  Required for travelers ≥1 year old arriving fr...   \n",
       "2               Algeria  Required for travelers ≥9 months old arriving ...   \n",
       "3  American Samoa  (US)                                               None   \n",
       "4               Andorra                                               None   \n",
       "5                Angola      Required for arriving travelers ≥9 months old   \n",
       "6       Anguilla (U.K.)                                               None   \n",
       "7            Antarctica                                               None   \n",
       "8   Antigua and Barbuda  Required for travelers ≥1 year old arriving fr...   \n",
       "9             Argentina                                               None   \n",
       "\n",
       "                                 CDC Recommendations  \\\n",
       "0                                                      \n",
       "1                                                      \n",
       "2                                                      \n",
       "3                                                      \n",
       "4                                                      \n",
       "5       Recommended: for all travelers ≥9 months old   \n",
       "6                                                      \n",
       "7                                                      \n",
       "8                                                      \n",
       "9  Recommended: for travelers ≥9 months old going...   \n",
       "\n",
       "                                  Transmission Areas Drug Resistance  \\\n",
       "0  All areas <2,500 m (≈8,200 ft) elevation (Apri...     Chloroquine   \n",
       "1                                                                      \n",
       "2                                                                      \n",
       "3                                                                      \n",
       "4                                                                      \n",
       "5                                                All     Chloroquine   \n",
       "6                                                                      \n",
       "7                                                                      \n",
       "8                                                                      \n",
       "9                                                                      \n",
       "\n",
       "                                             Species  \\\n",
       "0  P. vivax(primarily)\\nP. falciparum(less commonly)   \n",
       "1                                                      \n",
       "2                                                      \n",
       "3                                                      \n",
       "4                                                      \n",
       "5  P. falciparum(primarily)\\nP. malariae,P. ovale...   \n",
       "6                                                      \n",
       "7                                                      \n",
       "8                                                      \n",
       "9                                                      \n",
       "\n",
       "                        Recommended Chemoprophylaxis     Last Updated  \n",
       "0  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "1                                                     October 4, 2024  \n",
       "2                                                     October 4, 2024  \n",
       "3                                                     October 4, 2024  \n",
       "4                                                     October 4, 2024  \n",
       "5  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "6                                                     October 4, 2024  \n",
       "7                                                     October 4, 2024  \n",
       "8                                                     October 4, 2024  \n",
       "9                                                     October 4, 2024  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from bs4 import BeautifulSoup\n",
    "\n",
    "# Define the URL\n",
    "url = \"https://wwwnc.cdc.gov/travel/yellowbook/2024/preparing/yellow-fever-vaccine-malaria-prevention-by-country\"\n",
    "\n",
    "# Fetch the webpage\n",
    "response = requests.get(url)\n",
    "soup = BeautifulSoup(response.text, \"html.parser\")\n",
    "\n",
    "# Locate all country blocks\n",
    "country_blocks = soup.find_all(\"div\", class_=\"dyfm-block\")\n",
    "\n",
    "# Function to clean extracted text while preserving reference numbers\n",
    "def clean_text(text):\n",
    "    text = re.sub(r'\\s+', ' ', text)  # Replace multiple spaces/newlines with a single space\n",
    "    return text.strip()\n",
    "\n",
    "# Function to format lists with newlines\n",
    "def format_list(ul_element):\n",
    "    return \"\\n\".join([li.get_text(strip=True) for li in ul_element.find_all(\"li\")]) if ul_element else \"\"\n",
    "\n",
    "# Initialize a list to store extracted data\n",
    "data_list = []\n",
    "\n",
    "# Loop through each country section\n",
    "for country in country_blocks:\n",
    "    country_name = country.find(\"h2\").get_text(strip=True) if country.find(\"h2\") else \"\"\n",
    "\n",
    "    # Initialize extracted data dictionary (empty values instead of \"Not Found\")\n",
    "    extracted_data = {\n",
    "        \"Country\": country_name,\n",
    "        \"Entry Requirements\": \"\",\n",
    "        \"CDC Recommendations\": \"\",\n",
    "        \"Transmission Areas\": \"\",\n",
    "        \"Drug Resistance\": \"\",\n",
    "        \"Species\": \"\",\n",
    "        \"Recommended Chemoprophylaxis\": \"\",\n",
    "        \"Last Updated\": \"\"\n",
    "    }\n",
    "\n",
    "    # Extract Entry Requirements\n",
    "    paragraphs = country.find_all(\"p\")\n",
    "    for para in paragraphs:\n",
    "        strong_tag = para.find(\"strong\")\n",
    "        if strong_tag:\n",
    "            strong_text = strong_tag.get_text(strip=True)\n",
    "            if \"Entry requirements\" in strong_text:\n",
    "                entry_text = para.get_text(strip=True).replace(\"Entry requirements:\", \"\").strip()\n",
    "                extracted_data[\"Entry Requirements\"] = clean_text(entry_text)\n",
    "\n",
    "    # Extract CDC Recommendations\n",
    "    recommended = \"\"\n",
    "    generally_not_recommended = \"\"\n",
    "    not_recommended = \"\"\n",
    "\n",
    "    # Find the paragraph that contains \"CDC recommendations\"\n",
    "    cdc_recommendations_p = None\n",
    "    for para in paragraphs:\n",
    "        if \"CDC recommendations\" in para.get_text(strip=True):\n",
    "            cdc_recommendations_p = para\n",
    "            break\n",
    "\n",
    "    if cdc_recommendations_p:\n",
    "        full_text = cdc_recommendations_p.get_text(\" \", strip=True).replace(\"CDC recommendations:\", \"\").strip()\n",
    "\n",
    "        # Find all bold elements inside the CDC recommendations\n",
    "        bold_tags = cdc_recommendations_p.find_all(\"strong\")\n",
    "\n",
    "        # Create a mapping of recommendation types\n",
    "        recommendation_sections = {}\n",
    "\n",
    "        for bold in bold_tags:\n",
    "            bold_text = bold.get_text(strip=True)\n",
    "            start_idx = full_text.find(bold_text)\n",
    "            if start_idx != -1:\n",
    "                recommendation_sections[bold_text] = start_idx\n",
    "\n",
    "        # Sort by position in text\n",
    "        sorted_recommendations = sorted(recommendation_sections.items(), key=lambda x: x[1])\n",
    "\n",
    "        # Extract each recommendation text based on its position\n",
    "        extracted_texts = {}\n",
    "        for i, (label, start_idx) in enumerate(sorted_recommendations):\n",
    "            end_idx = sorted_recommendations[i + 1][1] if i + 1 < len(sorted_recommendations) else len(full_text)\n",
    "            extracted_texts[label] = full_text[start_idx + len(label):end_idx].strip()\n",
    "\n",
    "        # Assign extracted recommendations\n",
    "        recommended = extracted_texts.get(\"Recommended\", \"\").strip()\n",
    "        generally_not_recommended = extracted_texts.get(\"Generally not recommended\", \"\").strip()\n",
    "        not_recommended = extracted_texts.get(\"Not recommended\", \"\").strip()\n",
    "\n",
    "        # Format recommendations correctly with newlines\n",
    "        cdc_recommendations = []\n",
    "        if recommended:\n",
    "            cdc_recommendations.append(f\"Recommended: {recommended}\")\n",
    "        if generally_not_recommended:\n",
    "            cdc_recommendations.append(f\"Generally not recommended: {generally_not_recommended}\")\n",
    "        if not_recommended:\n",
    "            cdc_recommendations.append(f\"Not recommended: {not_recommended}\")\n",
    "\n",
    "        extracted_data[\"CDC Recommendations\"] = \"\\n\".join(cdc_recommendations)\n",
    "\n",
    "    # Extract Malaria Information\n",
    "    for para in paragraphs:\n",
    "        strong_tag = para.find(\"strong\")\n",
    "        if strong_tag:\n",
    "            strong_text = strong_tag.get_text(strip=True)\n",
    "            next_ul = para.find_next(\"ul\")  # Locate the closest <ul> element\n",
    "\n",
    "            if \"Transmission areas\" in strong_text and next_ul:\n",
    "                extracted_data[\"Transmission Areas\"] = format_list(next_ul)\n",
    "\n",
    "            elif \"Drug resistance\" in strong_text and next_ul:\n",
    "                extracted_data[\"Drug Resistance\"] = format_list(next_ul)\n",
    "\n",
    "            elif \"Species\" in strong_text and next_ul:\n",
    "                extracted_data[\"Species\"] = format_list(next_ul)\n",
    "\n",
    "            elif \"Recommended chemoprophylaxis\" in strong_text and next_ul:\n",
    "                extracted_data[\"Recommended Chemoprophylaxis\"] = format_list(next_ul)\n",
    "\n",
    "    # Extract Last Updated Date\n",
    "    last_updated = country.find(\"div\", class_=\"LastDateUpdate\")\n",
    "    if last_updated:\n",
    "        last_updated_text = last_updated.get_text(strip=True).replace(\"Date last updated:\", \"\").strip()\n",
    "        extracted_data[\"Last Updated\"] = last_updated_text  # Keep full date\n",
    "\n",
    "    # Append extracted data to list\n",
    "    data_list.append(extracted_data)\n",
    "\n",
    "# Convert to DataFrame\n",
    "df = pd.DataFrame(data_list)\n",
    "\n",
    "# # Save to CSV\n",
    "# df.to_csv(\"yellow_fever_malaria_data_cleaned.csv\", index=False)\n",
    "\n",
    "# Display the extracted DataFrame\n",
    "from IPython.display import display\n",
    "display(df.head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Country</th>\n",
       "      <th>Entry Requirements</th>\n",
       "      <th>CDC Recommendations</th>\n",
       "      <th>Transmission Areas</th>\n",
       "      <th>Drug Resistance</th>\n",
       "      <th>Species</th>\n",
       "      <th>Recommended Chemoprophylaxis</th>\n",
       "      <th>Last Updated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Argentina</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Country Entry Requirements  \\\n",
       "9  Argentina               None   \n",
       "\n",
       "                                 CDC Recommendations Transmission Areas  \\\n",
       "9  Recommended: for travelers ≥9 months old going...                      \n",
       "\n",
       "  Drug Resistance Species Recommended Chemoprophylaxis     Last Updated  \n",
       "9                                                       October 4, 2024  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df[\"Country\"] == \"Argentina\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'Country': 'Afghanistan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All areas <2,500 m (≈8,200 ft) elevation (April–December)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(primarily)\\nP. falciparum(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Albania',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Algeria',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'American Samoa  (US)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Andorra',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Angola',\n",
       "  'Entry Requirements': 'Required for arriving travelers ≥9 months old',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Anguilla (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Antarctica',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Antigua and Barbuda',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Argentina',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to Corrientes and Misiones Provinces.\\nGenerally not recommended: for travel to Formosa Province or to designated areas of Chaco, Jujuy, and Salta Provinces.\\nNot recommended: for travel limited to provinces and areas not listed above.',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Armenia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Aruba',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Entry will be denied if a valid vaccination certificate cannot be provided.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Australia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Austria',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Azerbaijan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Azores (Portugal)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bahamas, The',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bahrain',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bangladesh',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Districts of Chittagong Hill Tract (Bandarban, Khagrachari, and Rangamati); and the following districts: Chattogram (Chittagong) and Cox’s Bazar (in Chattogram [Chittagong] Division); Mymensingh, Netrakona, and Sherpur (in Mymensingh Division); Kurigram (in Rangpur Division); Habiganj, Moulvibazar, Sunamganj, and Sylhet (in Sylhet Division)\\nNo malaria transmission in Dhaka (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(80%)\\nP. vivax(20%)\\nP. malariae(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Barbados',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1Travelers arriving from Guyana or Trinidad & Tobago are exempt from this requirement, unless an outbreak is occurring.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Belarus',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Belgium',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Belize',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Benin',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale,andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bermuda (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bhutan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rare cases in rural areas <1,700 m (≈5,500 ft) elevation in districts along the southern border shared with India',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(primarily)\\nP. falciparum(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'None (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bolivia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation, east of the Andes Mountains: the entire departments of Beni, Pando, Santa Cruz, and designated areas in the departments of Chuquisaca, Cochabamba, La Paz, and Tarija.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation and any areas not listed above, including the cities of La Paz (administrative capital) and Sucre (constitutional [legislative and judicial] capital).',\n",
       "  'Transmission Areas': 'All areas <2,500 m (≈8,200 ft) elevation\\nNo malaria transmission in La Paz (administrative capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(99%)\\nP. falciparum(1%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, primaquine5,\\xa0tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bonaire',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bosnia and Herzegovina',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Botswana',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes transits through countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Districts/ subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North East (including its capital, Francistown), Okavango, Serowe/ Palapye, and Tutume\\nRare cases or sporadic foci of transmission in districts/ subdistricts of Kgalagadi North, Kgatleng, Kweneng, and Southern\\nNo malaria transmission in Gaborone (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAreas with rare cases or sporadic foci of transmission: no chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Brazil',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to the states of Acre, Amapá, Amazonas, Distrito Federal (including the capital city, Brasília), Espírito Santo,* Goiás, Maranhão, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Pará, Paraná,* Piauí, Rio de Janeiro (including the city of Rio de Janeiro and all coastal islands),* Rio Grande do Sul,* Rondônia, Roraima, Santa Catarina,* São Paulo (including the city of São Paulo and all coastal islands),* Tocantins, and designated areas of Bahia*. Vaccination is also recommended for travelers going to Iguaçu Falls.\\nNot recommended: for travel limited to any areas not listed above, including the cities of Fortaleza and Recife *In 2017, in response to a large YF outbreak in multiple eastern states, CDC expanded its vaccination recommendations for travelers going to Brazil. The expanded YF vaccination recommendations for these states are preliminary. For updates, refer to the CDC Travelers’ Health website.',\n",
       "  'Transmission Areas': 'All areas in the states of Acre, Amapá, Amazonas, Rondônia, and Roraima\\nPresent in the states of Maranhão, Mato Grosso, and Pará, but rare cases in their capital cities (São Luis [capital of Maranhão], Cuiabá [capital of Mato Grosso], Belém [capital of Pará])\\nRare cases and sporadic foci of transmission in rural and forested areas in the states of Espírito Santo, Goiás, Minas Gerais, Mato Grosso do Sul, Piauí, Rio de Janeiro, São Paolo, and Tocantins\\nNo malaria transmission in the cities of Brasília (the capital), Rio de Janeiro, or São Paolo\\nNo malaria transmission at Iguaçu Falls',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(90%)\\nP. falciparum(10%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAreas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'British Indian Ocean Territory; includes Diego Garcia (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Brunei',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'No human malaria\\nRare transmission ofP. knowlesi6in primarily forested or forest-fringe areas',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. knowlesi6(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'None (insect bite precautions and\\xa0mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Bulgaria',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Burkina Faso',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Burma (Myanmar)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All areas',\n",
       "  'Drug Resistance': 'Chloroquine and mefloquine',\n",
       "  'Species': 'P. vivax(80%)\\nP. falciparum(20%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Areas in the regions of Bago and Tanintharyi; and in the states of Kachin, Kayah, Kayin, and Shan: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Burundi',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cambodia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Primarily isolated to pockets in rural and forested areas\\nRare cases in non-forested areas\\nNo (or negligible) malaria transmission in the cities of Phnom Penh (the capital) and Siem Reap\\nNo (or negligible) malaria transmission at the main temple complex at Angkor Wat',\n",
       "  'Drug Resistance': 'Chloroquine and mefloquine',\n",
       "  'Species': 'P. vivax(95%)\\nP. falciparum(5%)\\nP. malariaeandP. knowlesi6(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Rural and forested areas: Atovaquone-proguanil, doxycycline, primaquine5, tafenoquine3\\nAreas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cameroon',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥1 year old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Canada',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Canary Islands ( Spain )',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cape Verde',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cayman Islands (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Central African Republic',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old .',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Chad',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Chile',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'China',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers with itineraries limited to Hong Kong Special Administrative Region (SAR) or Macao SAR are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Christmas Island (Australia)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cocos (Keeling) Islands (Australia)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Colombia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from Angola, Brazil, Democratic Republic of the Congo, or Uganda; this includes >12-hour airport transits or layovers in any of these countries.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the cities of Barranquilla, Cali, Cartagena, or Medellín.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, the archipelago department of San Andrés and Providencia, or the city of Bogotá (the capital).',\n",
       "  'Transmission Areas': 'All areas <1,700 m (≈5,600 ft) elevation\\nNo malaria transmission in the cities of Bogotá (the capital), Cartagena, or Medellín',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(50%)\\nP. vivax(50%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Comoros',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariaeandP. vivax(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Congo, Republic of the (Congo-Brazzaville)',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cook Islands (New Zealand)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Costa Rica',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1Included in this requirement are travelers arriving from Tanzania and Zambia, and designated areas of: Colombia (the entire country, except the cities of Barranquilla, Bogotá, Cali, Cartagena, and Medellín, and the archipelago department, San Andrés and Providencia); Ecuador (the provinces of Morona-Santiago, Napo, Orellana, Pastaza, Sucumbíos, and Zamora-Chinchipe, and excluding the rest of the country); Paraguay (the entire country, except the city of Asunción); Peru (the entire country, except the cities of Cusco and Lima, the regions of Cajamarca, Lambayeque, Piura, and Tumbes, and the highland tourist areas of Machu Picchu and the Inca Trail); Trinidad & Tobago (the entire country, except the urban areas of Port of Spain; travelers with itineraries limited to the island of Tobago, and travelers with airport transits or layovers are also exempt from this requirement). Travelers arriving from Argentina and Panama are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Present in the provinces of Alajuela and Limón\\nRare to no transmission in other parts of the country',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. falciparum(86%)\\nP. vivax(14%)',\n",
       "  'Recommended Chemoprophylaxis': 'Alajuela and Limón Provinces: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas: None (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': \"Côte d'Ivoire (Ivory Coast)\",\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Croatia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Cuba',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Curaçao, Netherlands',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': ''},\n",
       " {'Country': 'Cyprus',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Czechia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Democratic Republic of the Congo (Congo-Kinshasa)',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Denmark',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Djibouti',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(60–70%)\\nP. vivax(30–40%)\\nP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Dominica',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Dominican Republic',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from the following states in Brazil: Espírito Santo, Mina Gerais, Rio de Janeiro, São Paulo; this includes >12-hour airport transits or layovers in any of these states',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Primarily in the provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo\\nIn the Distrito Nacional, city of Santo Domingo (the capital), primarily in the La Ciénaga and Los Tres Brazos areas\\nRare transmission in other provinces',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. falciparum(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'Provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas: No chemoprophylaxis recommended (insect bite precautions and\\xa0mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Easter Island (Chile)',\n",
       "  'Entry Requirements': 'Easter Island has not stated its YF vaccination certificate requirements',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Ecuador, including the Galápagos Islands',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from Brazil, Democratic Republic of the Congo, or Uganda; this includes >12-hour airport transits or layovers in any of these countries .',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation, east of the Andes Mountains, in the provinces of Morona-Santiago, Napo, Orellana, Pastaza, Sucumbíos, Tungurahua,* and Zamora-Chinchipe.\\nGenerally not recommended: for travel limited to areas <2,300 m (≈7,550 ft) elevation, west of the Andes Mountains, in the provinces of Esmeraldas,* Guayas, Los Ríos, Manabí, Santa Elena, Santo Domingo de los Tsáchilas, and designated areas in the provinces of Azuay, Bolívar, Cañar, Carchi, Chimborazo, Cotopaxi, El Oro, Imbabura, Loja, and Pichincha.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, the cities of Guayaquil or Quito (the capital), or the Galápagos Islands *CDC recommendations differ from those published by WHO .',\n",
       "  'Transmission Areas': 'Areas <1,500 m (<5,000 ft) elevation in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos\\nRare cases <1,500 m (<5,000 ft) in all other provinces\\nNo malaria transmission in the cities of Guayaquil or Quito (the capital)\\nNo malaria transmission on the Galápagos Islands',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(85%)\\nP. falciparum(15%)',\n",
       "  'Recommended Chemoprophylaxis': 'Transmission areas in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos: Atovaquone-proguanil, doxycycline, mefloquine,\\xa0tafenoquine3\\nAll other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Egypt',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'El Salvador',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Equatorial Guinea',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae, P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Eritrea',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to the regions of: Anseba, Debub (also known as South or Southern Region), Gash Barka, Ma’ekel (also known as Ma’akel or Central Region), or Semenawi K’eyih Bahri (also known as Northern Red Sea Region).\\nNot recommended: for travel to any areas not listed above, including the Dahlak Archipelago.',\n",
       "  'Transmission Areas': 'All areas <2,200 m (≈7,200 ft) elevation\\nNo malaria transmission in Asmara (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(80–85%)\\nP. vivax(15–20%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Estonia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Eswatini (Swaziland)',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Eastern areas bordering Mozambique and South Africa, including the entire region of Lubombo and the eastern half of Hhohho, Manzini, and Shiselweni Regions',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale,\\xa0andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Ethiopia',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the regions of Afar or Somali.',\n",
       "  'Transmission Areas': 'All areas <2,500 m (<8,200 ft) elevation',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(70%)\\nP.\\xa0vivax(30%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'All areas <2,500m (8,200 ft) elevation: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'January 17, 2025'},\n",
       " {'Country': 'Falkland Islands (Islas Malvinas), UK Overseas Territory (also claimed by Argentina)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Faroe Islands (Denmark)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Fiji',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Finland',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'France',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'French Guiana',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥1 year old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'Areas associated with gold mining, primarily the communes near the border with Brazil and Suriname, especially Régina and Saint-Georges-de-l’Oyapock; also, the communes of Kourou, Matoury, and Saint-Élie\\nNo malaria transmission in coastal areas west of Kourou\\nNo malaria transmission in Cayenne City (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(85%)\\nP. falciparum(15%)\\nP. malariae(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'French Polynesia, including the Society Islands [Bora-Bora, Moorea & Tahiti]; Marquesas Islands [Hiva Oa & Ua Huka]; and Austral Islands (Tubuai & Rurutu), France',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Gabon',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Gambia, The',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Georgia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Germany',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Ghana',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale,andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Gibraltar (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Greece',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rare, local transmission in agricultural areas, associated with imported malaria (May–November)\\nNo malaria transmission in tourist\\u202fareas',\n",
       "  'Drug Resistance': 'Not applicable',\n",
       "  'Species': 'P. vivax(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'None',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Greenland (Denmark)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Grenada',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guadeloupe (including Marie-Galante, La Désirade & Îles des Saintes)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guam (U.S.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guatemala',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Primarily in the departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén\\nFew cases reported in other departments\\nNo malaria transmission in the cities of Antigua\\xa0or Guatemala City\\xa0(the capital)\\nNo malaria transmission at Lake Atitlán',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(99%)\\nP. falciparum(1%)',\n",
       "  'Recommended Chemoprophylaxis': 'Departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nOther areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and\\xa0mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guinea',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1Required for all arriving travelers from all countries if traveler is ≥9 months of age and arriving at Ahmed Sékou Touré International Airport in Conakry.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guinea-Bissau',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥1 year old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Guyana',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >4-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All\\nRare cases in the cities of Georgetown (the capital) and New Amsterdam',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(60%)\\nP. falciparum(40%)',\n",
       "  'Recommended Chemoprophylaxis': 'All areas (except the cities of Georgetown and New Amsterdam): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nCities of Georgetown and Amsterdam:\\xa0No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Haiti',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All (including Labadee, also known as Port Labadee)',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. falciparum(99%)\\nP. malariae(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Honduras',\n",
       "  'Entry Requirements': 'Required for travelers 1-60 years old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Throughout the country and on the island of\\xa0Roatán and other Bay Islands\\nNo malaria transmission in the cities of San Pedro Sula or Tegucigalpa (the capital)',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(70%)\\nP. falciparum(30%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, chloroquine,\\xa0doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Hong Kong (China)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Hungary',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Iceland',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'India',\n",
       "  'Entry Requirements': 'Any traveler ≥9 months old arriving by air or by sea without a YF vaccination certificate will be detained in isolation for ≤6 days if theyArrive within 6 days of leaving an area with risk for YF virus transmission, orHave been in such an area in transit (exception: passengers and members of flight crews who, while in transit through an airport in an area with risk for YF virus transmission, remained in the airport during their entire stay and the health officer agrees to such an exemption), orArrive on a ship that started from or touched at any port in an area with risk for YF virus transmission ≤30 days before its arrival in India, unless such a ship has been disinsected in accordance with the procedure recommended by the World Health Organization (WHO), orArrive on an aircraft that has been in an area with risk for YF virus transmission and has not been disinsected in accordance with the Indian Aircraft Public Health Rules, 1954, or as recommended by WHO.The following countries are regarded by the Government of India as areas with risk for YF virus transmission.Africa: Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, South Sudan, Sudan, Togo, UgandaAmericas: Argentina, Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay, Peru, Suriname, Trinidad & Tobago (Trinidad only), VenezuelaWhen a case of YF is reported from any country, the Government of India regards that country as an area with risk for YF virus transmission and adds it to the above list.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Throughout the country, including the cities of Bombay (Mumbai) and New Delhi (the capital)\\nNo malaria transmission in areas >2,000 m (>6,500 ft) elevation, which include areas in Arunachal Pradesh, Himachal Pradesh, Jammu and Kashmir, Kerala, Ladakh, Sikkim, Tamil Nadu, or Uttarakhand',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(60%)\\nP. vivax(40%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Indonesia',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All areas of eastern Indonesia (the provinces of Maluku, North Maluku, East Nusa Tenggara, Papua, and West Papua), including the town of Labuan Bajo and the Komodo Islands in the Nusa Tenggara region\\nRural areas of Kalimantan (Borneo), West Nusa Tenggara (includes the island of Lombok), Sulawesi, and Sumatra\\nLow transmission in rural areas of Java, including Pangandaran, Sukabumi, and Ujung Kulon\\nNo malaria transmission in the cities of Jakarta (the capital) or Ubud\\nNo malaria transmission in the resort areas of Bali or Java, the Gili Islands, or the Thousand Islands (Pulau Seribu)',\n",
       "  'Drug Resistance': 'Chloroquine (P. falciparumandP. vivax)',\n",
       "  'Species': 'P. falciparum(60%)\\nP. vivax(40%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Iran',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Previously, March–November in rural areas of Fars Province, Sistan-Baluchestan Province, and southern, tropical parts of Hormozgan and Kerman Provinces\\nRecent outbreaks in Sistan-Baluchestan Province near the border with Pakistan',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(90%)\\nP. falciparum(10%)',\n",
       "  'Recommended Chemoprophylaxis': 'Sistan-Baluchestan Province along the border with Pakistan: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2\\nAll other areas with previous transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Iraq',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Ireland',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Israel',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Italy (including Holy See [Vatican City])',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Jamaica',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Japan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Jordan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kazakhstan',\n",
       "  'Entry Requirements': 'Required for travelers arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kenya',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to: the city of Nairobi (the capital); the counties of the former North Eastern Province (Mandera, Wajir, and Garissa); or the counties (except Taita-Taveta) of the former Coast Province (Kilifi, including the city of Malindi; Kwale; Lamu; Mombasa, including the city of Mombasa; Tana River) .',\n",
       "  'Transmission Areas': 'All areas (including game parks) <2,500 m (<8,200 ft)\\xa0elevation; rare cases in the highly urbanized central part of the city of Nairobi (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nHighly urbanized central part of the city of Nairobi (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kiribati (formerly Gilbert Islands), includes Tarawa, Tabuaeran (Fanning Island), and Banaba (Ocean Island)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kosovo',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kuwait',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Kyrgyzstan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Laos',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Present in the southern part of the country in the provinces of Attapeu, Champasak, Khammouane, Salavan, Savannakhet, and Sekong\\nRare cases in the northern part of the country\\nNone in the cities of Luang Prabang and Vientiane (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine and mefloquine',\n",
       "  'Species': 'P. vivax(55%)\\nP. falciparum(45%)\\nP. knowlesi6, P. malariae,andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'In the provinces of Attapeu, Champasak, Khammouane, Salavan, Savannakhet, and Sekong: Atovaquone-proguanil, doxycycline, tafenoquine3\\nNorthern part of the country: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Latvia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Lebanon',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Lesotho',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Liberia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Libya',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Liechtenstein',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Lithuania',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Luxembourg',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Macau (China)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Madagascar',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All; except in Antananarivo (the capital) where malaria transmission is rare',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. ovaleandP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'All areas (except the city of Antananarivo): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAntananarivo: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Madeira Islands (Portugal)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Malawi',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Malaysia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'No indigenous cases of human malaria since 2017\\nZoonotic transmission of simian malaria occurs in rural, forested areas\\nNo malaria transmission in other areas, including Kuala Lumpur (the capital), in Penang State, on Penang Island, or in George Town (capital of Penang State)',\n",
       "  'Drug Resistance': 'Previously, chloroquine',\n",
       "  'Species': 'P. knowlesi6(primarily)\\nPreviously,P. falciparum,P. malariae,P.ovale, andP. vivax',\n",
       "  'Recommended Chemoprophylaxis': 'In rural, forested areas: atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Maldives',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mali',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Malta',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Marshall Islands',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Martinique',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mauritania',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.',\n",
       "  'Transmission Areas': 'All; except in the regions of Dakhlet Nouadhibou and Tiris Zemmour where there is no transmission',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mauritius',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mayotte (France)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rare cases',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'None (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mexico',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Campeche, Chiapas, and the southern part of Chihuahua state\\nRare in the states of Oaxaca, Sinaloa, Sonora, and Tabasco\\nNo malaria transmission along the US–Mexico border',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'Campeche, Chiapas, and the southern part of Chihuahua state: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Micronesia, Federated States of (including Chuuk, Kosrae, Pohnpei & Yap)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Moldova',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Monaco',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mongolia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Montenegro',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Montserrat, United Kingdom',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Morocco',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Mozambique',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Namibia',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'In the regions of Kavango (East and West), Kunene, Ohangwena, Omaheke, Omusati, Oshana, Oshikoto, Otjozondjupa, and Zambezi\\nRare in other parts of the country\\nNo malaria transmission in Windhoek (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Kavango (East and West), Kunene, Ohangwena, Omaheke, Omusati, Oshana, Oshikoto, Otjozondjupa, and Zambezi: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Nauru',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Nepal',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Sudurpashchim and Karnali provinces in areas <2,000m (<6,500 ft) elevation\\nRare cases in other areas throughout the country in areas <2,000 m (<6,500 ft) elevation\\nNo malaria transmission in Kathmandu (the capital), Pokhara, or on typical Himalayan treks',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(primarily)\\nP. falciparum(<10%)',\n",
       "  'Recommended Chemoprophylaxis': 'Areas <2,000m in Sudurpashchim and Kernali Provinces: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Netherlands',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Netherlands Antilles (Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten)',\n",
       "  'Entry Requirements': 'See Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten for yellow fever information.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'See Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten for malaria information.',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': ''},\n",
       " {'Country': 'New Caledonia (France)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1In the event of an epidemic threat to the territory, a specific vaccination certificate may be required.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'New Zealand',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Nicaragua',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Región Autónoma Atlántico Norte (RAAN) and Región Autónoma Atlántico Sur (RAAS)\\nRare cases in the departments of Boaco, Chinandega, Estelí, Jinotega, León, Matagalpa, and Nueva Segovia\\nNo malaria transmission in Managua (the capital)',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(80%)\\nP. falciparum(20%)',\n",
       "  'Recommended Chemoprophylaxis': 'Región Autónoma Atlántico Norte (RAAN) and Región Autónoma Atlántico Sur (RAAS): Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Niger',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Nigeria',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Niue (New Zealand)',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Norfolk Island (Australia)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'North Korea',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Southern provinces',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'North Macedonia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Northern Mariana Islands (U.S.), includes Saipan, Tinian, and Rota Island',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Norway',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Oman',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission, with the addition of Rwanda and Tanzania; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rare sporadic transmission after importation only',\n",
       "  'Drug Resistance': 'Previously, chloroquine',\n",
       "  'Species': 'Previously,P. falciparumandP. vivax',\n",
       "  'Recommended Chemoprophylaxis': 'None (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Pakistan',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All areas (including all cities) <2,500 m (≈8,200 ft) elevation',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(80%)\\nP. falciparum(20%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Palau',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Panama',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to all mainland areas east of the Canal Zone including Darién Province, the indigenous provinces (comarcas indígena) of Emberá and Kuna Yala (also spelled Guna Yala), and areas of the provinces of Colón and Panamá, east of the Canal Zone.\\nNot recommended: for travel limited to the Canal Zone; areas west of the Canal Zone; Panama City (the capital); Balboa district (Pearl Islands) of Panamá Province; or the San Blas Islands of Kuna Yala Province.',\n",
       "  'Transmission Areas': 'The provinces of Bocas del Toro, Chiriquí, Colón, Darién, Panamá, Panamá Oeste, and Veraguas\\nThe indigenous provinces (comarcas indígena) of Emberá,\\xa0Kuna Yala (also spelled Guna Yala) and Ngäbe-Buglé\\nNo malaria transmission in the Canal Zone\\xa0or in Panama City (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine (east of the Panama Canal)',\n",
       "  'Species': 'P. vivax(97%)\\nP. falciparum(3%)',\n",
       "  'Recommended Chemoprophylaxis': 'Darién, Emberá, Kuna Yala, and Panamá Provinces : Atovaquone-proguanil, doxycycline, mefloquine, primaquine5, tafenoquine3\\nBocas del Toro, Chiriquí, Colón, Ngäbe-Buglé, Panamá Oeste, and Veraguas Provinces : Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Papua New Guinea',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Throughout the country in areas <2,000 m (≈6,500 ft) elevation',\n",
       "  'Drug Resistance': 'Chloroquine (bothP. falciparumandP. vivax)',\n",
       "  'Species': 'P. falciparum(75%)\\nP. vivax(25%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Paraguay',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from Bolivia, Brazil, Peru, or Venezuela; this includes this includes >24-hour transits or layovers in those countries1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the city of Asunción (the capital).',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Peru',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation in the regions of Amazonas, Cusco, Huánuco, Junín, Loreto, Madre de Dios, Pasco, Puno, San Martín, and Ucayali, and designated areas of Ancash (far northeast), Apurímac (far north), Ayacucho (north and northeast), Cajamarca (north and east), Huancavelica (far north), La Libertad (east), and Piura (east).\\nGenerally not recommended: for travel limited to the following areas west of the Andes: the regions of Lambayeque and Tumbes, and designated areas of Cajamarca (west-central), and Piura (west).\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, areas west of the Andes not listed above, the city of Lima (the capital), and the highland tourist areas (the city of Cusco, the Inca Trail, and Machu Picchu).',\n",
       "  'Transmission Areas': 'All areas of the country <2,500 m (<8,200 ft) elevation east of the Andes, including the cities of Iquitos and Puerto Maldonado\\nRare cases in Tumbes and Piura regions\\nNo malaria transmission in the following areas: Lima Province; the cities of Arequipa, Ica, Moquegua, Nazca, Puno, or Tacna; the highland tourist areas (the city of Cusco, Machu Picchu, Lake Titicaca); along the central and southern Pacific Coast',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(80%)\\nP. falciparum(20%)',\n",
       "  'Recommended Chemoprophylaxis': 'Areas <2,500m (<8,200 ft) elevation east of the Andes (see map): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission (see map): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Philippines',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Province of Palawan and the Mindanao Island group\\nNo malaria transmission in metropolitan Manila (the capital) or other urban\\u202fareas',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(85%)\\nP. vivax(15%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Pitcairn Islands (U.K.)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Poland',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Portugal',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Puerto Rico (U.S.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Qatar',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Réunion (France)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Romania',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Russia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Rwanda',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to Rwanda.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saba, Netherlands',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saint Barthelemy, France',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': ''},\n",
       " {'Country': 'Saint Helena, United Kingdom',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1*For YF vaccine entry requirements and recommendations and malaria prevention information for Ascension Island and Tristan da Cunha archipelago, see: UNITED KINGDOM (including CHANNEL ISLANDS, ISLE OF MAN, ASCENSION ISLAND & TRISTAN DA CUNHA ARCHIPELAGO)',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saint Kitts (Saint Christopher) & Nevis',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saint Lucia',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saint Martin, France',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': ''},\n",
       " {'Country': 'Saint Pierre and Miquelon (France)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saint Vincent and the Grenadines',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Samoa (formerly Western Somoa)',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'San Marino',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'São Tomé and Príncipe',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to São Tomé and Príncipe.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Saudi Arabia',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Asir and Jazan (also spelled Jizan) Regions near the Yemen border only\\nNo malaria transmission in the cities of Jeddah, Mecca, Medina, Riyadh (the capital), or Ta’if',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. vivax(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Senegal',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Serbia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Seychelles',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sierra Leone',\n",
       "  'Entry Requirements': 'Required for all arriving travelers.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Singapore',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sint Eustatius, Netherlands',\n",
       "  'Entry Requirements': 'Required for travelers ≥6 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sint Maarten, Netherlands',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Slovakia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Slovenia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Solomon Islands',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(70%)\\nP. falciparum(30%)\\nP. ovale(<1%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Somalia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to the regions of Bakool, Banaadir, Bay, Galguduud, Gedo, Hiiraan (also spelled Hiran), Lower Juba (also known as Jubbada Hoose), Middle Juba (also known as Jubbada Dhexe), Lower Shabelle (also known as Shabeellaha Hoose), or Middle Shabelle (also known as Shabeellaha Dhexe).\\nNot recommended: for travel to areas not listed above.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(90%)\\nP. vivax(5–10%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'South Africa',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Along the border with Mozambique and Zimbabwe\\nKwaZulu-Natal Province: uMkhanyakude District; the districts of King Cetshwayo and Zululand (few cases) Limpopo Province: the districts of Mopani and Vhembe; the districts of Capricorn, Greater Sekhukhune, and Waterberg (few cases)\\nMpumalanga Province: Ehlanzeni District\\nKruger National Park',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'KwaZulu-Natal Province (uMkhanyakude District); Limpopo Province (the districts of Mopani and Vhembe); Mpumalanga Province (Ehlanzeni District); and Kruger National Park: Atovaquone-proguanil, doxycycline, mefloquine,\\xa0tafenoquine3\\nAll other areas with malaria transmission (including the districts of King Cetshwayo and Zululand in KwaZulu-Natal Province, and the districts of Capricorn, Greater Sekhukhune, and Waterberg in Limpopo Province): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'South Georgia & the South Sandwich Islands, UK Overseas Territory (also claimed by Argentina)',\n",
       "  'Entry Requirements': 'South Georgia & the South Sandwich Islands has not stated its YF vaccination certificate requirements.',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'South Korea',\n",
       "  'Entry Requirements': 'Required if traveling from a country with risk of YF virus transmission and ≥1 year of age.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Limited to the months of March– December in rural areas in the northern parts of the provinces of Inch’ŏn (also spelled Incheon), Kangwŏn (also spelled Gangwon), and Kyŏnggi (also spelled Gyeonggi), including the demilitarized zone (DMZ)',\n",
       "  'Drug Resistance': 'None',\n",
       "  'Species': 'P. vivax(100%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, or tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'South Sudan',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Spain',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sri Lanka',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sudan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert or the city of Khartoum (the capital).',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(90%)\\nP. vivax(5–10%)\\nP. malariaeandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Suriname',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'No indigenous cases since 2021\\nPreviously, primarily in Sipaliwini District, near the border with French Guiana, with limited transmission in Brokopondo, Marowijne, and Para\\xa0(near the border with French Guiana)',\n",
       "  'Drug Resistance': 'Previously, chloroquine',\n",
       "  'Species': 'Previously,P. vivax(primarily)\\nPreviously,P. falciparum(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'None\\xa0(insect bite precautions and\\xa0mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Sweden',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Switzerland',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Syria',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Taiwan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tajikistan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tanzania',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to Tanzania.',\n",
       "  'Transmission Areas': 'All areas below 1,800 m (≈5,900\\u202fft) elevation',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariaeandP. ovale(less commonly)\\nP. vivax(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Thailand',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Primarily\\xa0the provinces that border Burma (Myanmar), Cambodia (rare cases in Buri Ram Province), and Malaysia (especially in the rural forest and forest-fringe areas of these provinces)\\nRare to few cases in other parts of Thailand, including the cities of Bangkok (the capital), Chiang Mai, and Chiang Rai, or on the islands of Koh Pha Ngan, Koh Samui, or Phuket\\nNo malaria transmission on the islands of Krabi Province (Koh Lanta, Koh Phi Phi, Koh Yao Noi, Koh Yao Yai) or in Pattaya City',\n",
       "  'Drug Resistance': 'Chloroquine and mefloquine',\n",
       "  'Species': 'P. vivax(80%)\\nP. falciparum(<20%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Provinces that border Burma (Myanmar), Cambodia (except Buri Ram Province), and Malaysia: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas with malaria transmission (including Buri Ram province): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Timor-Leste',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rare cases; outbreak in Indonesia border area in 2020',\n",
       "  'Drug Resistance': 'Previously, chloroquine',\n",
       "  'Species': 'Previously,P. falciparum(50%)\\nPreviously,P. vivax(50%)\\nPreviously,P. malariaeandP. ovale(each <1%)',\n",
       "  'Recommended Chemoprophylaxis': 'None (insect bite precautions and\\xa0mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Togo',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥9 months old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tokelau (New Zealand)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tonga',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Trinidad and Tobago',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': 'Recommended: for travelers ≥9 months old going to densely forested areas on Trinidad.\\nNot recommended: for cruise ship passengers, airplane passengers in transit, or travel limited to Tobago.',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tunisia',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Türkiye (Turkey)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Turkmenistan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Turks and Caicos Islands (U.K.)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Tuvalu',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Uganda',\n",
       "  'Entry Requirements': 'Required for all arriving travelers ≥1 year old.',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Ukraine',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'United Arab Emirates',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'United Kingdom (including Channel Islands, Isle of Man, Ascension Island & Tristan Da Cunha Archipelago)',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'United States of America',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Uruguay',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Uzbekistan',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Vanuatu',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(primarily)\\nP. falciparumandP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Venezuela',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year old arriving from Brazil; this includes >12-hour airport transits or layovers in Brazil',\n",
       "  'CDC Recommendations': 'Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the Distrito Capital or the states of Aragua, Carabobo, Miranda, Vargas, or Yaracuy.\\nNot recommended: for travel limited to areas >2,300m (≈7,550 ft) elevation in the states of Mérida, Táchira, or Trujillo; the states of Falcón or Lara; Margarita Island; or the cities of Caracas (the capital) or Valencia .',\n",
       "  'Transmission Areas': 'All areas <1,700 m (≈5,600 ft) elevation and Angel Falls',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. vivax(75%)\\nP. falciparum(25%)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Vietnam',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'Rural areas only; rare cases in the Mekong and Red River Deltas\\nNone in the cities of Da Nang, Hai Phong, Hanoi, Ho Chi Minh City (Saigon), Nha Trang, and Quy Nhon',\n",
       "  'Drug Resistance': 'Chloroquine and mefloquine',\n",
       "  'Species': 'P. vivax(55%)\\nP. falciparum(44%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)',\n",
       "  'Recommended Chemoprophylaxis': 'Provinces of Bình Dương, Bình Phước, Đắk Lắk, Đắk Nông, Gia Lai, Khánh Hòa, Kon Tum, Lâm Đồng, Ninh Thuận, Tây Ninh: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas with malaria transmission (except Mekong and Red River Deltas): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nMekong and Red River Deltas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Virgin Islands, British',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Virgin Islands, U.S.',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Wake Island, U.S.',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': '',\n",
       "  'Drug Resistance': '',\n",
       "  'Species': '',\n",
       "  'Recommended Chemoprophylaxis': '',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Yemen',\n",
       "  'Entry Requirements': 'None',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All areas <2,000 m (≈6,500 ft) elevation\\nNo malaria transmission in Sana’a (the capital)',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Zambia',\n",
       "  'Entry Requirements': 'Required for travelers ≥1 year of age arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': 'Generally not recommended: for travel to North-Western Province or Western Province.\\nNot recommended: for travel to any areas not listed above.',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'},\n",
       " {'Country': 'Zimbabwe',\n",
       "  'Entry Requirements': 'Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1',\n",
       "  'CDC Recommendations': '',\n",
       "  'Transmission Areas': 'All',\n",
       "  'Drug Resistance': 'Chloroquine',\n",
       "  'Species': 'P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)',\n",
       "  'Recommended Chemoprophylaxis': 'Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3',\n",
       "  'Last Updated': 'October 4, 2024'}]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Country</th>\n",
       "      <th>Entry Requirements</th>\n",
       "      <th>CDC Recommendations</th>\n",
       "      <th>Transmission Areas</th>\n",
       "      <th>Drug Resistance</th>\n",
       "      <th>Species</th>\n",
       "      <th>Recommended Chemoprophylaxis</th>\n",
       "      <th>Last Updated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Afghanistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas &lt;2,500 m (≈8,200 ft) elevation (Apri...</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Albania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving fr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Algeria</td>\n",
       "      <td>Required for travelers ≥9 months old arriving ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>American Samoa  (US)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Andorra</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>Virgin Islands, U.S.</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>Wake Island, U.S.</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>Yemen</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas &lt;2,000 m (≈6,500 ft) elevation\\nNo m...</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale...</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>Zambia</td>\n",
       "      <td>Required for travelers ≥1 year of age arriving...</td>\n",
       "      <td>Generally not recommended: for travel to North...</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale...</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>Zimbabwe</td>\n",
       "      <td>Required for travelers ≥9 months old arriving ...</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale...</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>245 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                  Country                                 Entry Requirements  \\\n",
       "0             Afghanistan                                               None   \n",
       "1                 Albania  Required for travelers ≥1 year old arriving fr...   \n",
       "2                 Algeria  Required for travelers ≥9 months old arriving ...   \n",
       "3    American Samoa  (US)                                               None   \n",
       "4                 Andorra                                               None   \n",
       "..                    ...                                                ...   \n",
       "240  Virgin Islands, U.S.                                               None   \n",
       "241     Wake Island, U.S.                                               None   \n",
       "242                 Yemen                                               None   \n",
       "243                Zambia  Required for travelers ≥1 year of age arriving...   \n",
       "244              Zimbabwe  Required for travelers ≥9 months old arriving ...   \n",
       "\n",
       "                                   CDC Recommendations  \\\n",
       "0                                                        \n",
       "1                                                        \n",
       "2                                                        \n",
       "3                                                        \n",
       "4                                                        \n",
       "..                                                 ...   \n",
       "240                                                      \n",
       "241                                                      \n",
       "242                                                      \n",
       "243  Generally not recommended: for travel to North...   \n",
       "244                                                      \n",
       "\n",
       "                                    Transmission Areas Drug Resistance  \\\n",
       "0    All areas <2,500 m (≈8,200 ft) elevation (Apri...     Chloroquine   \n",
       "1                                                                        \n",
       "2                                                                        \n",
       "3                                                                        \n",
       "4                                                                        \n",
       "..                                                 ...             ...   \n",
       "240                                                                      \n",
       "241                                                                      \n",
       "242  All areas <2,000 m (≈6,500 ft) elevation\\nNo m...     Chloroquine   \n",
       "243                                                All     Chloroquine   \n",
       "244                                                All     Chloroquine   \n",
       "\n",
       "                                               Species  \\\n",
       "0    P. vivax(primarily)\\nP. falciparum(less commonly)   \n",
       "1                                                        \n",
       "2                                                        \n",
       "3                                                        \n",
       "4                                                        \n",
       "..                                                 ...   \n",
       "240                                                      \n",
       "241                                                      \n",
       "242  P. falciparum(primarily)\\nP. malariae,P. ovale...   \n",
       "243  P. falciparum(primarily)\\nP. malariae,P. ovale...   \n",
       "244  P. falciparum(primarily)\\nP. malariae,P. ovale...   \n",
       "\n",
       "                          Recommended Chemoprophylaxis     Last Updated  \n",
       "0    Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "1                                                       October 4, 2024  \n",
       "2                                                       October 4, 2024  \n",
       "3                                                       October 4, 2024  \n",
       "4                                                       October 4, 2024  \n",
       "..                                                 ...              ...  \n",
       "240                                                     October 4, 2024  \n",
       "241                                                     October 4, 2024  \n",
       "242  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "243  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "244  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024  \n",
       "\n",
       "[245 rows x 8 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "colorscale": [
          [
           0,
           "red"
          ],
          [
           1,
           "red"
          ]
         ],
         "customdata": [
          [
           "Afghanistan",
           "P. vivax(primarily)\nP. falciparum(less commonly)"
          ],
          [
           "Angola",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Bangladesh",
           "P. falciparum(80%)\nP. vivax(20%)\nP. malariae(rare)"
          ],
          [
           "Benin",
           "P. falciparum(primarily)\nP. malariae,P. ovale,andP. vivax(less commonly)"
          ],
          [
           "Bhutan",
           "P. vivax(primarily)\nP. falciparum(less commonly)"
          ],
          [
           "Bolivia",
           "P. vivax(99%)\nP. falciparum(1%)"
          ],
          [
           "Botswana",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Brazil",
           "P. vivax(90%)\nP. falciparum(10%)"
          ],
          [
           "Burkina Faso",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Burundi",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Cameroon",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Central African Republic",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Chad",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Colombia",
           "P. falciparum(50%)\nP. vivax(50%)"
          ],
          [
           "Comoros",
           "P. falciparum(primarily)\nP. malariaeandP. vivax(rare)"
          ],
          [
           "Congo, Republic of the (Congo-Brazzaville)",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Côte d'Ivoire (Ivory Coast)",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Democratic Republic of the Congo (Congo-Kinshasa)",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Djibouti",
           "P. falciparum(60–70%)\nP. vivax(30–40%)\nP. ovale(rare)"
          ],
          [
           "Ecuador, including the Galápagos Islands",
           "P. vivax(85%)\nP. falciparum(15%)"
          ],
          [
           "Equatorial Guinea",
           "P. falciparum(primarily)\nP. malariae, P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Eritrea",
           "P. falciparum(80–85%)\nP. vivax(15–20%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "Eswatini (Swaziland)",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Ethiopia",
           "P. falciparum(70%)\nP. vivax(30%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "French Guiana",
           "P. vivax(85%)\nP. falciparum(15%)\nP. malariae(rare)"
          ],
          [
           "Gabon",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Gambia, The",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Ghana",
           "P. falciparum(primarily)\nP. malariae,P. ovale,andP. vivax(less commonly)"
          ],
          [
           "Guinea",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Guinea-Bissau",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Guyana",
           "P. vivax(60%)\nP. falciparum(40%)"
          ],
          [
           "India",
           "P. falciparum(60%)\nP. vivax(40%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "Indonesia",
           "P. falciparum(60%)\nP. vivax(40%)\nP. knowlesi6,P. malariae, andP. ovale(rare)"
          ],
          [
           "Iran",
           "P. vivax(90%)\nP. falciparum(10%)"
          ],
          [
           "Kenya",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Liberia",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Madagascar",
           "P. falciparum(primarily)\nP. ovaleandP. vivax(less commonly)"
          ],
          [
           "Malawi",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Mali",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Mauritania",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Mayotte (France)",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Mozambique",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Namibia",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Nepal",
           "P. vivax(primarily)\nP. falciparum(<10%)"
          ],
          [
           "Niger",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Nigeria",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Pakistan",
           "P. vivax(80%)\nP. falciparum(20%)"
          ],
          [
           "Panama",
           "P. vivax(97%)\nP. falciparum(3%)"
          ],
          [
           "Papua New Guinea",
           "P. falciparum(75%)\nP. vivax(25%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "Peru",
           "P. vivax(80%)\nP. falciparum(20%)"
          ],
          [
           "Philippines",
           "P. falciparum(85%)\nP. vivax(15%)\nP. knowlesi6,P. malariae, andP. ovale(rare)"
          ],
          [
           "Rwanda",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "São Tomé and Príncipe",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Saudi Arabia",
           "P. falciparum(primarily)\nP. vivax(rare)"
          ],
          [
           "Senegal",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Sierra Leone",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Solomon Islands",
           "P. vivax(70%)\nP. falciparum(30%)\nP. ovale(<1%)"
          ],
          [
           "Somalia",
           "P. falciparum(90%)\nP. vivax(5–10%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "South Africa",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "South Sudan",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Sudan",
           "P. falciparum(90%)\nP. vivax(5–10%)\nP. malariaeandP. ovale(rare)"
          ],
          [
           "Tanzania",
           "P. falciparum(primarily)\nP. malariaeandP. ovale(less commonly)\nP. vivax(rare)"
          ],
          [
           "Togo",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Uganda",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Vanuatu",
           "P. vivax(primarily)\nP. falciparumandP. ovale(rare)"
          ],
          [
           "Venezuela",
           "P. vivax(75%)\nP. falciparum(25%)"
          ],
          [
           "Yemen",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Zambia",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ],
          [
           "Zimbabwe",
           "P. falciparum(primarily)\nP. malariae,P. ovale, andP. vivax(less commonly)"
          ]
         ],
         "geo": "geo",
         "hovertemplate": "Resistance Category=Chloroquine-resistant<br>Country=%{customdata[0]}<br>Species=%{customdata[1]}<extra></extra>",
         "locationmode": "country names",
         "locations": [
          "Afghanistan",
          "Angola",
          "Bangladesh",
          "Benin",
          "Bhutan",
          "Bolivia",
          "Botswana",
          "Brazil",
          "Burkina Faso",
          "Burundi",
          "Cameroon",
          "Central African Republic",
          "Chad",
          "Colombia",
          "Comoros",
          "Congo, Republic of the (Congo-Brazzaville)",
          "Côte d'Ivoire (Ivory Coast)",
          "Democratic Republic of the Congo (Congo-Kinshasa)",
          "Djibouti",
          "Ecuador, including the Galápagos Islands",
          "Equatorial Guinea",
          "Eritrea",
          "Eswatini (Swaziland)",
          "Ethiopia",
          "French Guiana",
          "Gabon",
          "Gambia, The",
          "Ghana",
          "Guinea",
          "Guinea-Bissau",
          "Guyana",
          "India",
          "Indonesia",
          "Iran",
          "Kenya",
          "Liberia",
          "Madagascar",
          "Malawi",
          "Mali",
          "Mauritania",
          "Mayotte (France)",
          "Mozambique",
          "Namibia",
          "Nepal",
          "Niger",
          "Nigeria",
          "Pakistan",
          "Panama",
          "Papua New Guinea",
          "Peru",
          "Philippines",
          "Rwanda",
          "São Tomé and Príncipe",
          "Saudi Arabia",
          "Senegal",
          "Sierra Leone",
          "Solomon Islands",
          "Somalia",
          "South Africa",
          "South Sudan",
          "Sudan",
          "Tanzania",
          "Togo",
          "Uganda",
          "Vanuatu",
          "Venezuela",
          "Yemen",
          "Zambia",
          "Zimbabwe"
         ],
         "name": "Chloroquine-resistant",
         "showlegend": true,
         "showscale": false,
         "type": "choropleth",
         "z": [
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1,
          1
         ]
        },
        {
         "colorscale": [
          [
           0,
           "purple"
          ],
          [
           1,
           "purple"
          ]
         ],
         "customdata": [
          [
           "Burma (Myanmar)",
           "P. vivax(80%)\nP. falciparum(20%)\nP. knowlesi6,P. malariae, andP. ovale(rare)"
          ],
          [
           "Cambodia",
           "P. vivax(95%)\nP. falciparum(5%)\nP. malariaeandP. knowlesi6(rare)"
          ],
          [
           "Laos",
           "P. vivax(55%)\nP. falciparum(45%)\nP. knowlesi6, P. malariae,andP. ovale(rare)"
          ],
          [
           "Thailand",
           "P. vivax(80%)\nP. falciparum(<20%)\nP. knowlesi6,P. malariae, andP. ovale(rare)"
          ],
          [
           "Vietnam",
           "P. vivax(55%)\nP. falciparum(44%)\nP. knowlesi6,P. malariae, andP. ovale(rare)"
          ]
         ],
         "geo": "geo",
         "hovertemplate": "Resistance Category=Chloroquine & Mefloquine resistant<br>Country=%{customdata[0]}<br>Species=%{customdata[1]}<extra></extra>",
         "locationmode": "country names",
         "locations": [
          "Burma (Myanmar)",
          "Cambodia",
          "Laos",
          "Thailand",
          "Vietnam"
         ],
         "name": "Chloroquine & Mefloquine resistant",
         "showlegend": true,
         "showscale": false,
         "type": "choropleth",
         "z": [
          1,
          1,
          1,
          1,
          1
         ]
        },
        {
         "colorscale": [
          [
           0,
           "blue"
          ],
          [
           1,
           "blue"
          ]
         ],
         "customdata": [
          [
           "Netherlands Antilles (Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten)",
           ""
          ]
         ],
         "geo": "geo",
         "hovertemplate": "Resistance Category=No Recorded Resistance<br>Country=%{customdata[0]}<br>Species=%{customdata[1]}<extra></extra>",
         "locationmode": "country names",
         "locations": [
          "Netherlands Antilles (Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten)"
         ],
         "name": "No Recorded Resistance",
         "showlegend": true,
         "showscale": false,
         "type": "choropleth",
         "z": [
          1
         ]
        }
       ],
       "layout": {
        "geo": {
         "center": {},
         "domain": {
          "x": [
           0,
           1
          ],
          "y": [
           0,
           1
          ]
         }
        },
        "legend": {
         "title": {
          "text": "Resistance Category"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Global Distribution of Malaria Drug Resistance"
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import plotly.express as px\n",
    "\n",
    "# Identify Chloroquine & Mefloquine resistance cases\n",
    "df[\"CQ_resist\"] = df[\"Drug Resistance\"].str.contains(\"Chloroquine\", na=False)\n",
    "df[\"MQ_resist\"] = df[\"Drug Resistance\"].str.contains(\"mefloquine\", na=False)\n",
    "\n",
    "# Assign resistance types (Include CQ, MQ, both resistant cases, and No Resistance)\n",
    "df[\"Resistance Type\"] = \"\"\n",
    "df.loc[df[\"CQ_resist\"], \"Resistance Type\"] = \"CQ-resist\"\n",
    "df.loc[df[\"MQ_resist\"], \"Resistance Type\"] = \"MQ-resist\"\n",
    "df.loc[df[\"CQ_resist\"] & df[\"MQ_resist\"], \"Resistance Type\"] = \"CQ & MQ resist\"\n",
    "\n",
    "# Identify countries with No malaria transmission\n",
    "df.loc[(df[\"Transmission Areas\"] == \"\"), \"Resistance Type\"] = \"No Malaria\"\n",
    "\n",
    "# Identify countries with malaria transmission but no recorded resistance\n",
    "df.loc[(df[\"Transmission Areas\"].notna()) & \n",
    "       (df[\"Transmission Areas\"] != \"\") & \n",
    "       (df[\"Drug Resistance\"] == \"\"), \"Resistance Type\"] = \"No Resistance\"\n",
    "\n",
    "# Filter out only the relevant cases\n",
    "df_filtered = df[df[\"Resistance Type\"].notna()].copy()\n",
    "\n",
    "# Define readable categories for visualization\n",
    "resistance_map = {\n",
    "    \"CQ-resist\": \"Chloroquine-resistant\",\n",
    "    \"MQ-resist\": \"Mefloquine-resistant\",\n",
    "    \"CQ & MQ resist\": \"Chloroquine & Mefloquine resistant\",\n",
    "    \"No Resistance\": \"No Recorded Resistance\"\n",
    "}\n",
    "df_filtered[\"Resistance Category\"] = df_filtered[\"Resistance Type\"].map(resistance_map)\n",
    "\n",
    "# Define color mapping for better visualization\n",
    "color_scheme = {\n",
    "    \"Chloroquine-resistant\": \"red\",\n",
    "    \"Mefloquine-resistant\": \"green\",\n",
    "    \"Chloroquine & Mefloquine resistant\": \"purple\",\n",
    "    \"No Recorded Resistance\": \"blue\"\n",
    "}\n",
    "\n",
    "# Create an interactive map with species information in hover tooltip\n",
    "fig = px.choropleth(\n",
    "    df_filtered,\n",
    "    locations=\"Country\",\n",
    "    locationmode=\"country names\",\n",
    "    color=\"Resistance Category\",\n",
    "    title=\"Global Distribution of Malaria Drug Resistance\",\n",
    "    color_discrete_map=color_scheme,\n",
    "    hover_data={\"Country\": True, \"Species\": True}  # Show species in tooltip\n",
    ")\n",
    "\n",
    "# Show the interactive map\n",
    "fig.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Country</th>\n",
       "      <th>Entry Requirements</th>\n",
       "      <th>CDC Recommendations</th>\n",
       "      <th>Transmission Areas</th>\n",
       "      <th>Drug Resistance</th>\n",
       "      <th>Species</th>\n",
       "      <th>Recommended Chemoprophylaxis</th>\n",
       "      <th>Last Updated</th>\n",
       "      <th>CQ_resist</th>\n",
       "      <th>MQ_resist</th>\n",
       "      <th>Resistance Type</th>\n",
       "      <th>Entry Category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Afghanistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas &lt;2,500 m (≈8,200 ft) elevation (Apri...</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Albania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving fr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Algeria</td>\n",
       "      <td>Required for travelers ≥9 months old arriving ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>American Samoa  (US)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Andorra</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Angola</td>\n",
       "      <td>Required for arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale...</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine,...</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Anguilla (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Antarctica</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Antigua and Barbuda</td>\n",
       "      <td>Required for travelers ≥1 year old arriving fr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Argentina</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                Country                                 Entry Requirements  \\\n",
       "0           Afghanistan                                               None   \n",
       "1               Albania  Required for travelers ≥1 year old arriving fr...   \n",
       "2               Algeria  Required for travelers ≥9 months old arriving ...   \n",
       "3  American Samoa  (US)                                               None   \n",
       "4               Andorra                                               None   \n",
       "5                Angola      Required for arriving travelers ≥9 months old   \n",
       "6       Anguilla (U.K.)                                               None   \n",
       "7            Antarctica                                               None   \n",
       "8   Antigua and Barbuda  Required for travelers ≥1 year old arriving fr...   \n",
       "9             Argentina                                               None   \n",
       "\n",
       "                                 CDC Recommendations  \\\n",
       "0                                                      \n",
       "1                                                      \n",
       "2                                                      \n",
       "3                                                      \n",
       "4                                                      \n",
       "5       Recommended: for all travelers ≥9 months old   \n",
       "6                                                      \n",
       "7                                                      \n",
       "8                                                      \n",
       "9  Recommended: for travelers ≥9 months old going...   \n",
       "\n",
       "                                  Transmission Areas Drug Resistance  \\\n",
       "0  All areas <2,500 m (≈8,200 ft) elevation (Apri...     Chloroquine   \n",
       "1                                                                      \n",
       "2                                                                      \n",
       "3                                                                      \n",
       "4                                                                      \n",
       "5                                                All     Chloroquine   \n",
       "6                                                                      \n",
       "7                                                                      \n",
       "8                                                                      \n",
       "9                                                                      \n",
       "\n",
       "                                             Species  \\\n",
       "0  P. vivax(primarily)\\nP. falciparum(less commonly)   \n",
       "1                                                      \n",
       "2                                                      \n",
       "3                                                      \n",
       "4                                                      \n",
       "5  P. falciparum(primarily)\\nP. malariae,P. ovale...   \n",
       "6                                                      \n",
       "7                                                      \n",
       "8                                                      \n",
       "9                                                      \n",
       "\n",
       "                        Recommended Chemoprophylaxis     Last Updated  \\\n",
       "0  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024   \n",
       "1                                                     October 4, 2024   \n",
       "2                                                     October 4, 2024   \n",
       "3                                                     October 4, 2024   \n",
       "4                                                     October 4, 2024   \n",
       "5  Atovaquone-proguanil, doxycycline, mefloquine,...  October 4, 2024   \n",
       "6                                                     October 4, 2024   \n",
       "7                                                     October 4, 2024   \n",
       "8                                                     October 4, 2024   \n",
       "9                                                     October 4, 2024   \n",
       "\n",
       "   CQ_resist  MQ_resist Resistance Type  \\\n",
       "0       True      False       CQ-resist   \n",
       "1      False      False      No Malaria   \n",
       "2      False      False      No Malaria   \n",
       "3      False      False      No Malaria   \n",
       "4      False      False      No Malaria   \n",
       "5       True      False       CQ-resist   \n",
       "6      False      False      No Malaria   \n",
       "7      False      False      No Malaria   \n",
       "8      False      False      No Malaria   \n",
       "9      False      False      No Malaria   \n",
       "\n",
       "                                      Entry Category  \n",
       "0                                               None  \n",
       "1  Arriving from countries with risk for YF virus...  \n",
       "2  Arriving from countries with risk for YF virus...  \n",
       "3                                               None  \n",
       "4                                               None  \n",
       "5                Required for all arriving travelers  \n",
       "6                                               None  \n",
       "7                                               None  \n",
       "8  Arriving from countries with risk for YF virus...  \n",
       "9                                               None  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Function to categorize Yellow Fever Entry Requirements\n",
    "def categorize_entry_requirements(text):\n",
    "    if pd.isna(text) or text.strip().lower() in [\"none\", \"no requirements\", \"not required\", \"\"]:\n",
    "        return \"None\"\n",
    "    elif re.search(r\"arriving\\s*from\\s*countries\\s*with\\s*risk\\s*for\\s*YF\\s*virus\\s*transmission\", text, re.IGNORECASE):\n",
    "        return \"Arriving from countries with risk for YF virus transmission\"\n",
    "    elif re.search(r\"required\\s*for\\s*(all\\s*)?arriving\\s*travelers\", text, re.IGNORECASE):\n",
    "        return \"Required for all arriving travelers\"\n",
    "    else:\n",
    "        return \"Other\"\n",
    "\n",
    "# Apply categorization to the existing DataFrame\n",
    "df[\"Entry Category\"] = df[\"Entry Requirements\"].apply(categorize_entry_requirements)\n",
    "\n",
    "# Display the updated DataFrame\n",
    "from IPython.display import display\n",
    "display(df.head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Save to CSV\n",
    "# df.to_csv(\"yellow_fever_malaria_data_cleaned_yfcat.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # Export the final DataFrame to an Excel file\n",
    "# df.to_excel(\"yellow_fever_malaria_data_cleaned_yfcat.xlsx\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define dictionary to map unrecognized territories to recognized countries\n",
    "\n",
    "tableau_mapping = {\n",
    "    \"Azores (Portugal)\": \"Azores\",\n",
    "    \"British Indian Ocean Territory; includes Diego Garcia (U.K.)\": \"British Indian Ocean Territory\",\n",
    "    \"Canary Islands ( Spain )\": \"Canary Islands\",\n",
    "    \"Christmas Island (Australia)\": \"Christmas Island\",\n",
    "    \"Cocos (Keeling) Islands (Australia)\": \"Cocos (Keeling) Islands\",\n",
    "    \"Cook Islands (New Zealand)\": \"Cook Islands\",\n",
    "    \"Curaçao, Netherlands\": \"Curaçao\",\n",
    "    \"Congo, Republic of the (Congo-Brazzaville)\": \"Republic of Congo\",\n",
    "    \"Democratic Republic of the Congo (Congo-Kinshasa)\": \"Democratic Republic of Congo\",\n",
    "    \"Easter Island (Chile)\": \"Easter Island\",\n",
    "    \"Ecuador, including the Galápagos Islands\": \"Ecuador\",\n",
    "    \"Eswatini (Swaziland)\": \"Eswatini\",\n",
    "    \"Falkland Islands (Islas Malvinas), UK Overseas Territory (also claimed by Argentina)\": \"Falkland Islands (Islas Malvinas)\",\n",
    "    \"Faroe Islands (Denmark)\": \"Faroe Islands\",\n",
    "    \"French Polynesia, including the Society Islands [Bora-Bora, Moorea & Tahiti]; Marquesas Islands [Hiva Oa & Ua Huka]; and Austral Islands (Tubuai & Rurutu), France\": \"French Polynesia\",\n",
    "    \"Gibraltar (U.K.)\": \"Gibraltar\",\n",
    "    \"Greenland (Denmark)\": \"Greenland\",\n",
    "    \"Guadeloupe (including Marie-Galante, La Désirade & Îles des Saintes)\": \"Guadeloupe\",\n",
    "    \"Italy (including Holy See [Vatican City])\" : \"Italy\",\n",
    "    \"Kiribati (formerly Gilbert Islands), includes Tarawa, Tabuaeran (Fanning Island), and Banaba (Ocean Island)\": \"Kiribati\",\n",
    "    \"Macau (China)\": \"Macau\",\n",
    "    \"Madeira Islands (Portugal)\": \"Madeira Islands\",\n",
    "    \"Mayotte (France)\": \"Mayotte\",\n",
    "    \"Micronesia, Federated States of (including Chuuk, Kosrae, Pohnpei & Yap)\": \"Federated States of Micronesia\",\n",
    "    \"Montserrat, United Kingdom\": \"Montserrat\",\n",
    "    \"Netherlands Antilles (Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten)\": \"Netherlands Antilles\",\n",
    "    \"Niue (New Zealand)\": \"Niue\",\n",
    "    \"Norfolk Island (Australia)\": \"Norfolk Island\",\n",
    "    \"Northern Mariana Islands (U.S.), includes Saipan, Tinian, and Rota Island\": \"Northern Mariana Islands\",\n",
    "    \"Saba, Netherlands\": \"Saba\",\n",
    "    \"Saint Barthelemy, France\": \"Saint Barthelemy\",\n",
    "    \"Saint Helena, United Kingdom\": \"Saint Helena\",\n",
    "    \"Saint Kitts (Saint Christopher) & Nevis\": \"Saint Kitts and Nevis\",\n",
    "    \"Saint Martin, France\": \"Saint Martin\",\n",
    "    \"Saint Pierre and Miquelon (France)\": \"Saint Pierre and Miquelon\",\n",
    "    \"Samoa (formerly Western Somoa)\": \"Samoa\",\n",
    "    \"Sint Eustatius, Netherlands\": \"Sint Eustatius\",\n",
    "    \"Sint Maarten, Netherlands\": \"Sint Maarten (Dutch part)\",\n",
    "    \"South Georgia & the South Sandwich Islands, UK Overseas Territory (also claimed by Argentina)\": \"South Georgia and the South Sandwich Islands\",\n",
    "    \"Tokelau (New Zealand)\": \"Tokelau\",\n",
    "    \"Türkiye (Turkey)\": \"Turkey\",\n",
    "    \"Turks and Caicos Islands (U.K.)\": \"Turks and Caicos Islands\",\n",
    "    \"United Kingdom (including Channel Islands, Isle of Man, Ascension Island & Tristan Da Cunha Archipelago)\": \"United Kingdom\",\n",
    "    \"Wake Island, U.S.\": \"Wake Island\"\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define a function to get the correct country name to match with Tableau data\n",
    "def get_country_tableau(country_name):\n",
    "    if country_name not in tableau_mapping:\n",
    "        return country_name\n",
    "    mapped_value = tableau_mapping[country_name]\n",
    "    if mapped_value == \"Unrecognized\":\n",
    "        return country_name\n",
    "    else:\n",
    "        return mapped_value"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a new column in df_csv\n",
    "df[\"Country_Tableau\"] = df[\"Country\"].apply(get_country_tableau)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Export the final DataFrame to an Excel file\n",
    "df.to_excel(\"yellow_fever_malaria_data_cleaned_yfcat_tableau.xlsx\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe display nowrap\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>Country</th>\n",
       "      <th>Entry Requirements</th>\n",
       "      <th>CDC Recommendations</th>\n",
       "      <th>Transmission Areas</th>\n",
       "      <th>Drug Resistance</th>\n",
       "      <th>Species</th>\n",
       "      <th>Recommended Chemoprophylaxis</th>\n",
       "      <th>Last Updated</th>\n",
       "      <th>CQ_resist</th>\n",
       "      <th>MQ_resist</th>\n",
       "      <th>Resistance Type</th>\n",
       "      <th>Entry Category</th>\n",
       "      <th>Country_Tableau</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>Afghanistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas <2,500 m (≈8,200 ft) elevation (April–December)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Afghanistan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Albania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Albania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Algeria</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Algeria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>American Samoa  (US)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>American Samoa  (US)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Andorra</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Andorra</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Angola</td>\n",
       "      <td>Required for arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Angola</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Anguilla (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Anguilla (U.K.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Antarctica</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Antarctica</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Antigua and Barbuda</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Antigua and Barbuda</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Argentina</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to Corrientes and Misiones Provinces.\\nGenerally not recommended: for travel to Formosa Province or to designated areas of Chaco, Jujuy, and Salta Provinces.\\nNot recommended: for travel limited to provinces and areas not listed above.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Argentina</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Armenia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Armenia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Aruba</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Entry will be denied if a valid vaccination certificate cannot be provided.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Aruba</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Australia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Australia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Austria</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Austria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Azerbaijan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Azerbaijan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Azores (Portugal)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Azores</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bahamas, The</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Bahamas, The</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bahrain</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Bahrain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bangladesh</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Districts of Chittagong Hill Tract (Bandarban, Khagrachari, and Rangamati); and the following districts: Chattogram (Chittagong) and Cox’s Bazar (in Chattogram [Chittagong] Division); Mymensingh, Netrakona, and Sherpur (in Mymensingh Division); Kurigram (in Rangpur Division); Habiganj, Moulvibazar, Sunamganj, and Sylhet (in Sylhet Division)\\nNo malaria transmission in Dhaka (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(80%)\\nP. vivax(20%)\\nP. malariae(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Bangladesh</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Barbados</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1Travelers arriving from Guyana or Trinidad & Tobago are exempt from this requirement, unless an outbreak is occurring.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Barbados</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Belarus</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Belarus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Belgium</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Belgium</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Belize</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Belize</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Benin</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale,andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Benin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bermuda (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Bermuda (U.K.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bhutan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Rare cases in rural areas <1,700 m (≈5,500 ft) elevation in districts along the southern border shared with India</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(less commonly)</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Bhutan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bolivia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation, east of the Andes Mountains: the entire departments of Beni, Pando, Santa Cruz, and designated areas in the departments of Chuquisaca, Cochabamba, La Paz, and Tarija.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation and any areas not listed above, including the cities of La Paz (administrative capital) and Sucre (constitutional [legislative and judicial] capital).</td>\n",
       "      <td>All areas <2,500 m (≈8,200 ft) elevation\\nNo malaria transmission in La Paz (administrative capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(99%)\\nP. falciparum(1%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, primaquine5, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Bolivia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bonaire</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Bonaire</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bosnia and Herzegovina</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Bosnia and Herzegovina</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Botswana</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes transits through countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Districts/ subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North East (including its capital, Francistown), Okavango, Serowe/ Palapye, and Tutume\\nRare cases or sporadic foci of transmission in districts/ subdistricts of Kgalagadi North, Kgatleng, Kweneng, and Southern\\nNo malaria transmission in Gaborone (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Districts/subdistricts of Bobirwa, Boteti, Chobe (including Chobe National Park), Ghanzi, Mahalapye, Ngamiland (Ngami), North-East (including its capital, Francistown), Okavango, Serowe/Palapye, and Tutume: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAreas with rare cases or sporadic foci of transmission: no chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Botswana</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Brazil</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to the states of Acre, Amapá, Amazonas, Distrito Federal (including the capital city, Brasília), Espírito Santo,* Goiás, Maranhão, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Pará, Paraná,* Piauí, Rio de Janeiro (including the city of Rio de Janeiro and all coastal islands),* Rio Grande do Sul,* Rondônia, Roraima, Santa Catarina,* São Paulo (including the city of São Paulo and all coastal islands),* Tocantins, and designated areas of Bahia*. Vaccination is also recommended for travelers going to Iguaçu Falls.\\nNot recommended: for travel limited to any areas not listed above, including the cities of Fortaleza and Recife *In 2017, in response to a large YF outbreak in multiple eastern states, CDC expanded its vaccination recommendations for travelers going to Brazil. The expanded YF vaccination recommendations for these states are preliminary. For updates, refer to the CDC Travelers’ Health website.</td>\n",
       "      <td>All areas in the states of Acre, Amapá, Amazonas, Rondônia, and Roraima\\nPresent in the states of Maranhão, Mato Grosso, and Pará, but rare cases in their capital cities (São Luis [capital of Maranhão], Cuiabá [capital of Mato Grosso], Belém [capital of Pará])\\nRare cases and sporadic foci of transmission in rural and forested areas in the states of Espírito Santo, Goiás, Minas Gerais, Mato Grosso do Sul, Piauí, Rio de Janeiro, São Paolo, and Tocantins\\nNo malaria transmission in the cities of Brasília (the capital), Rio de Janeiro, or São Paolo\\nNo malaria transmission at Iguaçu Falls</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(90%)\\nP. falciparum(10%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAreas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Brazil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>British Indian Ocean Territory; includes Diego Garcia (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>British Indian Ocean Territory</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Brunei</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>No human malaria\\nRare transmission ofP. knowlesi6in primarily forested or forest-fringe areas</td>\n",
       "      <td>None</td>\n",
       "      <td>P. knowlesi6(100%)</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Brunei</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Bulgaria</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Bulgaria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Burkina Faso</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Burkina Faso</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Burma (Myanmar)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All areas</td>\n",
       "      <td>Chloroquine and mefloquine</td>\n",
       "      <td>P. vivax(80%)\\nP. falciparum(20%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)</td>\n",
       "      <td>Areas in the regions of Bago and Tanintharyi; and in the states of Kachin, Kayah, Kayin, and Shan: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>CQ & MQ resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Burma (Myanmar)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Burundi</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Burundi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cambodia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Primarily isolated to pockets in rural and forested areas\\nRare cases in non-forested areas\\nNo (or negligible) malaria transmission in the cities of Phnom Penh (the capital) and Siem Reap\\nNo (or negligible) malaria transmission at the main temple complex at Angkor Wat</td>\n",
       "      <td>Chloroquine and mefloquine</td>\n",
       "      <td>P. vivax(95%)\\nP. falciparum(5%)\\nP. malariaeandP. knowlesi6(rare)</td>\n",
       "      <td>Rural and forested areas: Atovaquone-proguanil, doxycycline, primaquine5, tafenoquine3\\nAreas with rare cases: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>CQ & MQ resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Cambodia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cameroon</td>\n",
       "      <td>Required for all arriving travelers ≥1 year old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Cameroon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Canada</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Canada</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Canary Islands ( Spain )</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Canary Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cape Verde</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Cape Verde</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cayman Islands (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Cayman Islands (U.K.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Central African Republic</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old .</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Central African Republic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Chad</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Chad</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Chile</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Chile</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>China</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers with itineraries limited to Hong Kong Special Administrative Region (SAR) or Macao SAR are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Christmas Island (Australia)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Christmas Island</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cocos (Keeling) Islands (Australia)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Cocos (Keeling) Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Colombia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from Angola, Brazil, Democratic Republic of the Congo, or Uganda; this includes >12-hour airport transits or layovers in any of these countries.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the cities of Barranquilla, Cali, Cartagena, or Medellín.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, the archipelago department of San Andrés and Providencia, or the city of Bogotá (the capital).</td>\n",
       "      <td>All areas <1,700 m (≈5,600 ft) elevation\\nNo malaria transmission in the cities of Bogotá (the capital), Cartagena, or Medellín</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(50%)\\nP. vivax(50%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Other</td>\n",
       "      <td>Colombia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Comoros</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariaeandP. vivax(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Comoros</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Congo, Republic of the (Congo-Brazzaville)</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Republic of Congo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cook Islands (New Zealand)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Cook Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Costa Rica</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1Included in this requirement are travelers arriving from Tanzania and Zambia, and designated areas of: Colombia (the entire country, except the cities of Barranquilla, Bogotá, Cali, Cartagena, and Medellín, and the archipelago department, San Andrés and Providencia); Ecuador (the provinces of Morona-Santiago, Napo, Orellana, Pastaza, Sucumbíos, and Zamora-Chinchipe, and excluding the rest of the country); Paraguay (the entire country, except the city of Asunción); Peru (the entire country, except the cities of Cusco and Lima, the regions of Cajamarca, Lambayeque, Piura, and Tumbes, and the highland tourist areas of Machu Picchu and the Inca Trail); Trinidad & Tobago (the entire country, except the urban areas of Port of Spain; travelers with itineraries limited to the island of Tobago, and travelers with airport transits or layovers are also exempt from this requirement). Travelers arriving from Argentina and Panama are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td>Present in the provinces of Alajuela and Limón\\nRare to no transmission in other parts of the country</td>\n",
       "      <td>None</td>\n",
       "      <td>P. falciparum(86%)\\nP. vivax(14%)</td>\n",
       "      <td>Alajuela and Limón Provinces: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas: None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Costa Rica</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Côte d'Ivoire (Ivory Coast)</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Côte d'Ivoire (Ivory Coast)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Croatia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Croatia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cuba</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Cuba</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Curaçao, Netherlands</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Curaçao</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Cyprus</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Cyprus</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Czechia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Czechia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Democratic Republic of the Congo (Congo-Kinshasa)</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Democratic Republic of Congo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Denmark</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Denmark</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Djibouti</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(60–70%)\\nP. vivax(30–40%)\\nP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Djibouti</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Dominica</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Dominica</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Dominican Republic</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from the following states in Brazil: Espírito Santo, Mina Gerais, Rio de Janeiro, São Paulo; this includes >12-hour airport transits or layovers in any of these states</td>\n",
       "      <td></td>\n",
       "      <td>Primarily in the provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo\\nIn the Distrito Nacional, city of Santo Domingo (the capital), primarily in the La Ciénaga and Los Tres Brazos areas\\nRare transmission in other provinces</td>\n",
       "      <td>None</td>\n",
       "      <td>P. falciparum(100%)</td>\n",
       "      <td>Provinces (including resort areas) of Azua, Elias Piña, La Altagracia, San Juan, and Santo Domingo: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Other</td>\n",
       "      <td>Dominican Republic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Easter Island (Chile)</td>\n",
       "      <td>Easter Island has not stated its YF vaccination certificate requirements</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Other</td>\n",
       "      <td>Easter Island</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Ecuador, including the Galápagos Islands</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from Brazil, Democratic Republic of the Congo, or Uganda; this includes >12-hour airport transits or layovers in any of these countries .</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation, east of the Andes Mountains, in the provinces of Morona-Santiago, Napo, Orellana, Pastaza, Sucumbíos, Tungurahua,* and Zamora-Chinchipe.\\nGenerally not recommended: for travel limited to areas <2,300 m (≈7,550 ft) elevation, west of the Andes Mountains, in the provinces of Esmeraldas,* Guayas, Los Ríos, Manabí, Santa Elena, Santo Domingo de los Tsáchilas, and designated areas in the provinces of Azuay, Bolívar, Cañar, Carchi, Chimborazo, Cotopaxi, El Oro, Imbabura, Loja, and Pichincha.\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, the cities of Guayaquil or Quito (the capital), or the Galápagos Islands *CDC recommendations differ from those published by WHO .</td>\n",
       "      <td>Areas <1,500 m (<5,000 ft) elevation in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos\\nRare cases <1,500 m (<5,000 ft) in all other provinces\\nNo malaria transmission in the cities of Guayaquil or Quito (the capital)\\nNo malaria transmission on the Galápagos Islands</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(85%)\\nP. falciparum(15%)</td>\n",
       "      <td>Transmission areas in the provinces of Cotopaxi, Esmeraldas, Morona-Santiago, Orellana, Pastaza, and Sucumbíos: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Other</td>\n",
       "      <td>Ecuador</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Egypt</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Egypt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>El Salvador</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>El Salvador</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Equatorial Guinea</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae, P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Equatorial Guinea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Eritrea</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Generally not recommended: for travel to the regions of: Anseba, Debub (also known as South or Southern Region), Gash Barka, Ma’ekel (also known as Ma’akel or Central Region), or Semenawi K’eyih Bahri (also known as Northern Red Sea Region).\\nNot recommended: for travel to any areas not listed above, including the Dahlak Archipelago.</td>\n",
       "      <td>All areas <2,200 m (≈7,200 ft) elevation\\nNo malaria transmission in Asmara (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(80–85%)\\nP. vivax(15–20%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Eritrea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Estonia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Estonia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Eswatini (Swaziland)</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Eastern areas bordering Mozambique and South Africa, including the entire region of Lubombo and the eastern half of Hhohho, Manzini, and Shiselweni Regions</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Eswatini</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Ethiopia</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the regions of Afar or Somali.</td>\n",
       "      <td>All areas <2,500 m (<8,200 ft) elevation</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(70%)\\nP. vivax(30%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>All areas <2,500m (8,200 ft) elevation: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>January 17, 2025</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Ethiopia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Falkland Islands (Islas Malvinas), UK Overseas Territory (also claimed by Argentina)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Falkland Islands (Islas Malvinas)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Faroe Islands (Denmark)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Faroe Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Fiji</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Fiji</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Finland</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Finland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>France</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>France</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>French Guiana</td>\n",
       "      <td>Required for all arriving travelers ≥1 year old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>Areas associated with gold mining, primarily the communes near the border with Brazil and Suriname, especially Régina and Saint-Georges-de-l’Oyapock; also, the communes of Kourou, Matoury, and Saint-Élie\\nNo malaria transmission in coastal areas west of Kourou\\nNo malaria transmission in Cayenne City (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(85%)\\nP. falciparum(15%)\\nP. malariae(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>French Guiana</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>French Polynesia, including the Society Islands [Bora-Bora, Moorea & Tahiti]; Marquesas Islands [Hiva Oa & Ua Huka]; and Austral Islands (Tubuai & Rurutu), France</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>French Polynesia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Gabon</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Gabon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Gambia, The</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Gambia, The</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Georgia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Georgia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Germany</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Ghana</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale,andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Ghana</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Gibraltar (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Gibraltar</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Greece</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Rare, local transmission in agricultural areas, associated with imported malaria (May–November)\\nNo malaria transmission in tourist areas</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>P. vivax(100%)</td>\n",
       "      <td>None</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>None</td>\n",
       "      <td>Greece</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Greenland (Denmark)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Greenland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Grenada</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Grenada</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guadeloupe (including Marie-Galante, La Désirade & Îles des Saintes)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Guadeloupe</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guam (U.S.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Guam (U.S.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guatemala</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Primarily in the departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén\\nFew cases reported in other departments\\nNo malaria transmission in the cities of Antigua or Guatemala City (the capital)\\nNo malaria transmission at Lake Atitlán</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(99%)\\nP. falciparum(1%)</td>\n",
       "      <td>Departments of Alta Verapaz, Baja Verapaz, Escuintla, Izabal, and Petén: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nOther areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Guatemala</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guinea</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1Required for all arriving travelers from all countries if traveler is ≥9 months of age and arriving at Ahmed Sékou Touré International Airport in Conakry.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Guinea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guinea-Bissau</td>\n",
       "      <td>Required for all arriving travelers ≥1 year old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Guinea-Bissau</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Guyana</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >4-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All\\nRare cases in the cities of Georgetown (the capital) and New Amsterdam</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(60%)\\nP. falciparum(40%)</td>\n",
       "      <td>All areas (except the cities of Georgetown and New Amsterdam): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nCities of Georgetown and Amsterdam: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Guyana</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Haiti</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All (including Labadee, also known as Port Labadee)</td>\n",
       "      <td>None</td>\n",
       "      <td>P. falciparum(99%)\\nP. malariae(rare)</td>\n",
       "      <td>Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Haiti</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Honduras</td>\n",
       "      <td>Required for travelers 1-60 years old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Throughout the country and on the island of Roatán and other Bay Islands\\nNo malaria transmission in the cities of San Pedro Sula or Tegucigalpa (the capital)</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(70%)\\nP. falciparum(30%)</td>\n",
       "      <td>Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Honduras</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Hong Kong (China)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Hong Kong (China)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Hungary</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Hungary</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Iceland</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Iceland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>India</td>\n",
       "      <td>Any traveler ≥9 months old arriving by air or by sea without a YF vaccination certificate will be detained in isolation for ≤6 days if theyArrive within 6 days of leaving an area with risk for YF virus transmission, orHave been in such an area in transit (exception: passengers and members of flight crews who, while in transit through an airport in an area with risk for YF virus transmission, remained in the airport during their entire stay and the health officer agrees to such an exemption), orArrive on a ship that started from or touched at any port in an area with risk for YF virus transmission ≤30 days before its arrival in India, unless such a ship has been disinsected in accordance with the procedure recommended by the World Health Organization (WHO), orArrive on an aircraft that has been in an area with risk for YF virus transmission and has not been disinsected in accordance with the Indian Aircraft Public Health Rules, 1954, or as recommended by WHO.The following countries are regarded by the Government of India as areas with risk for YF virus transmission.Africa: Angola, Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, South Sudan, Sudan, Togo, UgandaAmericas: Argentina, Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay, Peru, Suriname, Trinidad & Tobago (Trinidad only), VenezuelaWhen a case of YF is reported from any country, the Government of India regards that country as an area with risk for YF virus transmission and adds it to the above list.</td>\n",
       "      <td></td>\n",
       "      <td>Throughout the country, including the cities of Bombay (Mumbai) and New Delhi (the capital)\\nNo malaria transmission in areas >2,000 m (>6,500 ft) elevation, which include areas in Arunachal Pradesh, Himachal Pradesh, Jammu and Kashmir, Kerala, Ladakh, Sikkim, Tamil Nadu, or Uttarakhand</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(60%)\\nP. vivax(40%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Other</td>\n",
       "      <td>India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Indonesia</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All areas of eastern Indonesia (the provinces of Maluku, North Maluku, East Nusa Tenggara, Papua, and West Papua), including the town of Labuan Bajo and the Komodo Islands in the Nusa Tenggara region\\nRural areas of Kalimantan (Borneo), West Nusa Tenggara (includes the island of Lombok), Sulawesi, and Sumatra\\nLow transmission in rural areas of Java, including Pangandaran, Sukabumi, and Ujung Kulon\\nNo malaria transmission in the cities of Jakarta (the capital) or Ubud\\nNo malaria transmission in the resort areas of Bali or Java, the Gili Islands, or the Thousand Islands (Pulau Seribu)</td>\n",
       "      <td>Chloroquine (P. falciparumandP. vivax)</td>\n",
       "      <td>P. falciparum(60%)\\nP. vivax(40%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Indonesia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Iran</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Previously, March–November in rural areas of Fars Province, Sistan-Baluchestan Province, and southern, tropical parts of Hormozgan and Kerman Provinces\\nRecent outbreaks in Sistan-Baluchestan Province near the border with Pakistan</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(90%)\\nP. falciparum(10%)</td>\n",
       "      <td>Sistan-Baluchestan Province along the border with Pakistan: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2\\nAll other areas with previous transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Iran</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Iraq</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Iraq</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Ireland</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Ireland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Israel</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Israel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Italy (including Holy See [Vatican City])</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Italy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Jamaica</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Jamaica</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Japan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Japan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Jordan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Jordan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kazakhstan</td>\n",
       "      <td>Required for travelers arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Kazakhstan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kenya</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to: the city of Nairobi (the capital); the counties of the former North Eastern Province (Mandera, Wajir, and Garissa); or the counties (except Taita-Taveta) of the former Coast Province (Kilifi, including the city of Malindi; Kwale; Lamu; Mombasa, including the city of Mombasa; Tana River) .</td>\n",
       "      <td>All areas (including game parks) <2,500 m (<8,200 ft) elevation; rare cases in the highly urbanized central part of the city of Nairobi (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nHighly urbanized central part of the city of Nairobi (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kiribati (formerly Gilbert Islands), includes Tarawa, Tabuaeran (Fanning Island), and Banaba (Ocean Island)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Kiribati</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kosovo</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Kosovo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kuwait</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Kuwait</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Kyrgyzstan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Kyrgyzstan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Laos</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Present in the southern part of the country in the provinces of Attapeu, Champasak, Khammouane, Salavan, Savannakhet, and Sekong\\nRare cases in the northern part of the country\\nNone in the cities of Luang Prabang and Vientiane (the capital)</td>\n",
       "      <td>Chloroquine and mefloquine</td>\n",
       "      <td>P. vivax(55%)\\nP. falciparum(45%)\\nP. knowlesi6, P. malariae,andP. ovale(rare)</td>\n",
       "      <td>In the provinces of Attapeu, Champasak, Khammouane, Salavan, Savannakhet, and Sekong: Atovaquone-proguanil, doxycycline, tafenoquine3\\nNorthern part of the country: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>CQ & MQ resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Laos</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Latvia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Latvia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Lebanon</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Lebanon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Lesotho</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Lesotho</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Liberia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Liberia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Libya</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Libya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Liechtenstein</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Liechtenstein</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Lithuania</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Lithuania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Luxembourg</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Luxembourg</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Macau (China)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Macau</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Madagascar</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All; except in Antananarivo (the capital) where malaria transmission is rare</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. ovaleandP. vivax(less commonly)</td>\n",
       "      <td>All areas (except the city of Antananarivo): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAntananarivo: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Madagascar</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Madeira Islands (Portugal)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Madeira Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Malawi</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Malawi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Malaysia</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>No indigenous cases of human malaria since 2017\\nZoonotic transmission of simian malaria occurs in rural, forested areas\\nNo malaria transmission in other areas, including Kuala Lumpur (the capital), in Penang State, on Penang Island, or in George Town (capital of Penang State)</td>\n",
       "      <td>Previously, chloroquine</td>\n",
       "      <td>P. knowlesi6(primarily)\\nPreviously,P. falciparum,P. malariae,P.ovale, andP. vivax</td>\n",
       "      <td>In rural, forested areas: atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Malaysia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Maldives</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Maldives</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mali</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Mali</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Malta</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Malta</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Marshall Islands</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Marshall Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Martinique</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Martinique</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mauritania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.</td>\n",
       "      <td>All; except in the regions of Dakhlet Nouadhibou and Tiris Zemmour where there is no transmission</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Mauritania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mauritius</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Mauritius</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mayotte (France)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Rare cases</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Mayotte</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mexico</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Campeche, Chiapas, and the southern part of Chihuahua state\\nRare in the states of Oaxaca, Sinaloa, Sonora, and Tabasco\\nNo malaria transmission along the US–Mexico border</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(100%)</td>\n",
       "      <td>Campeche, Chiapas, and the southern part of Chihuahua state: Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>None</td>\n",
       "      <td>Mexico</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Micronesia, Federated States of (including Chuuk, Kosrae, Pohnpei & Yap)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Federated States of Micronesia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Moldova</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Moldova</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Monaco</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Monaco</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mongolia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Mongolia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Montenegro</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Montenegro</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Montserrat, United Kingdom</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Montserrat</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Morocco</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Morocco</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Mozambique</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Mozambique</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Namibia</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>In the regions of Kavango (East and West), Kunene, Ohangwena, Omaheke, Omusati, Oshana, Oshikoto, Otjozondjupa, and Zambezi\\nRare in other parts of the country\\nNo malaria transmission in Windhoek (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Kavango (East and West), Kunene, Ohangwena, Omaheke, Omusati, Oshana, Oshikoto, Otjozondjupa, and Zambezi: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Namibia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Nauru</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Nauru</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Nepal</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Sudurpashchim and Karnali provinces in areas <2,000m (<6,500 ft) elevation\\nRare cases in other areas throughout the country in areas <2,000 m (<6,500 ft) elevation\\nNo malaria transmission in Kathmandu (the capital), Pokhara, or on typical Himalayan treks</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparum(<10%)</td>\n",
       "      <td>Areas <2,000m in Sudurpashchim and Kernali Provinces: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with reported malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Nepal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Netherlands</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Netherlands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Netherlands Antilles (Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten)</td>\n",
       "      <td>See Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten for yellow fever information.</td>\n",
       "      <td></td>\n",
       "      <td>See Bonaire, Curaçao, Saba, St. Eustasius, and St. Maarten for malaria information.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Resistance</td>\n",
       "      <td>Other</td>\n",
       "      <td>Netherlands Antilles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>New Caledonia (France)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1In the event of an epidemic threat to the territory, a specific vaccination certificate may be required.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>New Caledonia (France)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>New Zealand</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>New Zealand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Nicaragua</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Región Autónoma Atlántico Norte (RAAN) and Región Autónoma Atlántico Sur (RAAS)\\nRare cases in the departments of Boaco, Chinandega, Estelí, Jinotega, León, Matagalpa, and Nueva Segovia\\nNo malaria transmission in Managua (the capital)</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(80%)\\nP. falciparum(20%)</td>\n",
       "      <td>Región Autónoma Atlántico Norte (RAAN) and Región Autónoma Atlántico Sur (RAAS): Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Nicaragua</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Niger</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Niger</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Nigeria</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Nigeria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Niue (New Zealand)</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Niue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Norfolk Island (Australia)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1Travelers arriving from the Galápagos Islands of Ecuador are exempt from this requirement.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Norfolk Island</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>North Korea</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Southern provinces</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(100%)</td>\n",
       "      <td>Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>North Korea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>North Macedonia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>North Macedonia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Northern Mariana Islands (U.S.), includes Saipan, Tinian, and Rota Island</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Northern Mariana Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Norway</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Norway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Oman</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission, with the addition of Rwanda and Tanzania; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Rare sporadic transmission after importation only</td>\n",
       "      <td>Previously, chloroquine</td>\n",
       "      <td>Previously,P. falciparumandP. vivax</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Oman</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Pakistan</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All areas (including all cities) <2,500 m (≈8,200 ft) elevation</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(80%)\\nP. falciparum(20%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Pakistan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Palau</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Palau</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Panama</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to all mainland areas east of the Canal Zone including Darién Province, the indigenous provinces (comarcas indígena) of Emberá and Kuna Yala (also spelled Guna Yala), and areas of the provinces of Colón and Panamá, east of the Canal Zone.\\nNot recommended: for travel limited to the Canal Zone; areas west of the Canal Zone; Panama City (the capital); Balboa district (Pearl Islands) of Panamá Province; or the San Blas Islands of Kuna Yala Province.</td>\n",
       "      <td>The provinces of Bocas del Toro, Chiriquí, Colón, Darién, Panamá, Panamá Oeste, and Veraguas\\nThe indigenous provinces (comarcas indígena) of Emberá, Kuna Yala (also spelled Guna Yala) and Ngäbe-Buglé\\nNo malaria transmission in the Canal Zone or in Panama City (the capital)</td>\n",
       "      <td>Chloroquine (east of the Panama Canal)</td>\n",
       "      <td>P. vivax(97%)\\nP. falciparum(3%)</td>\n",
       "      <td>Darién, Emberá, Kuna Yala, and Panamá Provinces : Atovaquone-proguanil, doxycycline, mefloquine, primaquine5, tafenoquine3\\nBocas del Toro, Chiriquí, Colón, Ngäbe-Buglé, Panamá Oeste, and Veraguas Provinces : Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, tafenoquine3\\nAll other areas with malaria transmission: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Panama</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Papua New Guinea</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Throughout the country in areas <2,000 m (≈6,500 ft) elevation</td>\n",
       "      <td>Chloroquine (bothP. falciparumandP. vivax)</td>\n",
       "      <td>P. falciparum(75%)\\nP. vivax(25%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Papua New Guinea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Paraguay</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from Bolivia, Brazil, Peru, or Venezuela; this includes this includes >24-hour transits or layovers in those countries1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the city of Asunción (the capital).</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Other</td>\n",
       "      <td>Paraguay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Peru</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas <2,300 m (≈7,550 ft) elevation in the regions of Amazonas, Cusco, Huánuco, Junín, Loreto, Madre de Dios, Pasco, Puno, San Martín, and Ucayali, and designated areas of Ancash (far northeast), Apurímac (far north), Ayacucho (north and northeast), Cajamarca (north and east), Huancavelica (far north), La Libertad (east), and Piura (east).\\nGenerally not recommended: for travel limited to the following areas west of the Andes: the regions of Lambayeque and Tumbes, and designated areas of Cajamarca (west-central), and Piura (west).\\nNot recommended: for travel limited to areas >2,300 m (≈7,550 ft) elevation, areas west of the Andes not listed above, the city of Lima (the capital), and the highland tourist areas (the city of Cusco, the Inca Trail, and Machu Picchu).</td>\n",
       "      <td>All areas of the country <2,500 m (<8,200 ft) elevation east of the Andes, including the cities of Iquitos and Puerto Maldonado\\nRare cases in Tumbes and Piura regions\\nNo malaria transmission in the following areas: Lima Province; the cities of Arequipa, Ica, Moquegua, Nazca, Puno, or Tacna; the highland tourist areas (the city of Cusco, Machu Picchu, Lake Titicaca); along the central and southern Pacific Coast</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(80%)\\nP. falciparum(20%)</td>\n",
       "      <td>Areas <2,500m (<8,200 ft) elevation east of the Andes (see map): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission (see map): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Peru</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Philippines</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Province of Palawan and the Mindanao Island group\\nNo malaria transmission in metropolitan Manila (the capital) or other urban areas</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(85%)\\nP. vivax(15%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Philippines</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Pitcairn Islands (U.K.)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Pitcairn Islands (U.K.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Poland</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Poland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Portugal</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Portugal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Puerto Rico (U.S.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Puerto Rico (U.S.)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Qatar</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Qatar</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Réunion (France)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Réunion (France)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Romania</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Romania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Russia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Russia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Rwanda</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td>Generally not recommended: for travel to Rwanda.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Rwanda</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saba, Netherlands</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Saba</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Barthelemy, France</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Barthelemy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Helena, United Kingdom</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1*For YF vaccine entry requirements and recommendations and malaria prevention information for Ascension Island and Tristan da Cunha archipelago, see: UNITED KINGDOM (including CHANNEL ISLANDS, ISLE OF MAN, ASCENSION ISLAND & TRISTAN DA CUNHA ARCHIPELAGO)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Helena</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Kitts (Saint Christopher) & Nevis</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Kitts and Nevis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Lucia</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Lucia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Martin, France</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Martin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Pierre and Miquelon (France)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Saint Pierre and Miquelon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saint Vincent and the Grenadines</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saint Vincent and the Grenadines</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Samoa (formerly Western Somoa)</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Samoa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>San Marino</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>San Marino</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>São Tomé and Príncipe</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Generally not recommended: for travel to São Tomé and Príncipe.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>São Tomé and Príncipe</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Saudi Arabia</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Asir and Jazan (also spelled Jizan) Regions near the Yemen border only\\nNo malaria transmission in the cities of Jeddah, Mecca, Medina, Riyadh (the capital), or Ta’if</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. vivax(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Saudi Arabia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Senegal</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Senegal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Serbia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Serbia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Seychelles</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Seychelles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sierra Leone</td>\n",
       "      <td>Required for all arriving travelers.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Sierra Leone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Singapore</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Singapore</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sint Eustatius, Netherlands</td>\n",
       "      <td>Required for travelers ≥6 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Sint Eustatius</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sint Maarten, Netherlands</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Sint Maarten (Dutch part)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Slovakia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Slovakia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Slovenia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Slovenia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Solomon Islands</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(70%)\\nP. falciparum(30%)\\nP. ovale(<1%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Solomon Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Somalia</td>\n",
       "      <td>None</td>\n",
       "      <td>Generally not recommended: for travel to the regions of Bakool, Banaadir, Bay, Galguduud, Gedo, Hiiraan (also spelled Hiran), Lower Juba (also known as Jubbada Hoose), Middle Juba (also known as Jubbada Dhexe), Lower Shabelle (also known as Shabeellaha Hoose), or Middle Shabelle (also known as Shabeellaha Dhexe).\\nNot recommended: for travel to areas not listed above.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(90%)\\nP. vivax(5–10%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Somalia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>South Africa</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Along the border with Mozambique and Zimbabwe\\nKwaZulu-Natal Province: uMkhanyakude District; the districts of King Cetshwayo and Zululand (few cases) Limpopo Province: the districts of Mopani and Vhembe; the districts of Capricorn, Greater Sekhukhune, and Waterberg (few cases)\\nMpumalanga Province: Ehlanzeni District\\nKruger National Park</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>KwaZulu-Natal Province (uMkhanyakude District); Limpopo Province (the districts of Mopani and Vhembe); Mpumalanga Province (Ehlanzeni District); and Kruger National Park: Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nAll other areas with malaria transmission (including the districts of King Cetshwayo and Zululand in KwaZulu-Natal Province, and the districts of Capricorn, Greater Sekhukhune, and Waterberg in Limpopo Province): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>South Africa</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>South Georgia & the South Sandwich Islands, UK Overseas Territory (also claimed by Argentina)</td>\n",
       "      <td>South Georgia & the South Sandwich Islands has not stated its YF vaccination certificate requirements.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Other</td>\n",
       "      <td>South Georgia and the South Sandwich Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>South Korea</td>\n",
       "      <td>Required if traveling from a country with risk of YF virus transmission and ≥1 year of age.1</td>\n",
       "      <td></td>\n",
       "      <td>Limited to the months of March– December in rural areas in the northern parts of the provinces of Inch’ŏn (also spelled Incheon), Kangwŏn (also spelled Gangwon), and Kyŏnggi (also spelled Gyeonggi), including the demilitarized zone (DMZ)</td>\n",
       "      <td>None</td>\n",
       "      <td>P. vivax(100%)</td>\n",
       "      <td>Atovaquone-proguanil, chloroquine, doxycycline, mefloquine, primaquine5, or tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Other</td>\n",
       "      <td>South Korea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>South Sudan</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>South Sudan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Spain</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Spain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sri Lanka</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Sri Lanka</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sudan</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to areas south of the Sahara Desert.\\nNot recommended: for travel limited to areas in the Sahara Desert or the city of Khartoum (the capital).</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(90%)\\nP. vivax(5–10%)\\nP. malariaeandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Sudan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Suriname</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>No indigenous cases since 2021\\nPreviously, primarily in Sipaliwini District, near the border with French Guiana, with limited transmission in Brokopondo, Marowijne, and Para (near the border with French Guiana)</td>\n",
       "      <td>Previously, chloroquine</td>\n",
       "      <td>Previously,P. vivax(primarily)\\nPreviously,P. falciparum(rare)</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Suriname</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Sweden</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Sweden</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Switzerland</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Switzerland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Syria</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Syria</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Taiwan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Taiwan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tajikistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Tajikistan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tanzania</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Generally not recommended: for travel to Tanzania.</td>\n",
       "      <td>All areas below 1,800 m (≈5,900 ft) elevation</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariaeandP. ovale(less commonly)\\nP. vivax(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Tanzania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Thailand</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>Primarily the provinces that border Burma (Myanmar), Cambodia (rare cases in Buri Ram Province), and Malaysia (especially in the rural forest and forest-fringe areas of these provinces)\\nRare to few cases in other parts of Thailand, including the cities of Bangkok (the capital), Chiang Mai, and Chiang Rai, or on the islands of Koh Pha Ngan, Koh Samui, or Phuket\\nNo malaria transmission on the islands of Krabi Province (Koh Lanta, Koh Phi Phi, Koh Yao Noi, Koh Yao Yai) or in Pattaya City</td>\n",
       "      <td>Chloroquine and mefloquine</td>\n",
       "      <td>P. vivax(80%)\\nP. falciparum(<20%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)</td>\n",
       "      <td>Provinces that border Burma (Myanmar), Cambodia (except Buri Ram Province), and Malaysia: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas with malaria transmission (including Buri Ram province): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>CQ & MQ resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Thailand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Timor-Leste</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Rare cases; outbreak in Indonesia border area in 2020</td>\n",
       "      <td>Previously, chloroquine</td>\n",
       "      <td>Previously,P. falciparum(50%)\\nPreviously,P. vivax(50%)\\nPreviously,P. malariaeandP. ovale(each <1%)</td>\n",
       "      <td>None (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td></td>\n",
       "      <td>None</td>\n",
       "      <td>Timor-Leste</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Togo</td>\n",
       "      <td>Required for all arriving travelers ≥9 months old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Togo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tokelau (New Zealand)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Tokelau</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tonga</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Tonga</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Trinidad and Tobago</td>\n",
       "      <td>None</td>\n",
       "      <td>Recommended: for travelers ≥9 months old going to densely forested areas on Trinidad.\\nNot recommended: for cruise ship passengers, airplane passengers in transit, or travel limited to Tobago.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Trinidad and Tobago</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tunisia</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Tunisia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Türkiye (Turkey)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Turkey</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Turkmenistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Turkmenistan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Turks and Caicos Islands (U.K.)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Turks and Caicos Islands</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Tuvalu</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Tuvalu</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Uganda</td>\n",
       "      <td>Required for all arriving travelers ≥1 year old.</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Required for all arriving travelers</td>\n",
       "      <td>Uganda</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Ukraine</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Ukraine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>United Arab Emirates</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>United Arab Emirates</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>United Kingdom (including Channel Islands, Isle of Man, Ascension Island & Tristan Da Cunha Archipelago)</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>United States of America</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>United States of America</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Uruguay</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Uruguay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Uzbekistan</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Uzbekistan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Vanuatu</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(primarily)\\nP. falciparumandP. ovale(rare)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Vanuatu</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Venezuela</td>\n",
       "      <td>Required for travelers ≥1 year old arriving from Brazil; this includes >12-hour airport transits or layovers in Brazil</td>\n",
       "      <td>Recommended: for all travelers ≥9 months old except as follows.\\nGenerally not recommended: for travel limited to the Distrito Capital or the states of Aragua, Carabobo, Miranda, Vargas, or Yaracuy.\\nNot recommended: for travel limited to areas >2,300m (≈7,550 ft) elevation in the states of Mérida, Táchira, or Trujillo; the states of Falcón or Lara; Margarita Island; or the cities of Caracas (the capital) or Valencia .</td>\n",
       "      <td>All areas <1,700 m (≈5,600 ft) elevation and Angel Falls</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. vivax(75%)\\nP. falciparum(25%)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Other</td>\n",
       "      <td>Venezuela</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Vietnam</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>Rural areas only; rare cases in the Mekong and Red River Deltas\\nNone in the cities of Da Nang, Hai Phong, Hanoi, Ho Chi Minh City (Saigon), Nha Trang, and Quy Nhon</td>\n",
       "      <td>Chloroquine and mefloquine</td>\n",
       "      <td>P. vivax(55%)\\nP. falciparum(44%)\\nP. knowlesi6,P. malariae, andP. ovale(rare)</td>\n",
       "      <td>Provinces of Bình Dương, Bình Phước, Đắk Lắk, Đắk Nông, Gia Lai, Khánh Hòa, Kon Tum, Lâm Đồng, Ninh Thuận, Tây Ninh: Atovaquone-proguanil, doxycycline, tafenoquine3\\nAll other areas with malaria transmission (except Mekong and Red River Deltas): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3\\nMekong and Red River Deltas: No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>CQ & MQ resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Vietnam</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Virgin Islands, British</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Virgin Islands, British</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Virgin Islands, U.S.</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Virgin Islands, U.S.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Wake Island, U.S.</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No Malaria</td>\n",
       "      <td>None</td>\n",
       "      <td>Wake Island</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Yemen</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>All areas <2,000 m (≈6,500 ft) elevation\\nNo malaria transmission in Sana’a (the capital)</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>None</td>\n",
       "      <td>Yemen</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Zambia</td>\n",
       "      <td>Required for travelers ≥1 year of age arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td>Generally not recommended: for travel to North-Western Province or Western Province.\\nNot recommended: for travel to any areas not listed above.</td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Zambia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>Zimbabwe</td>\n",
       "      <td>Required for travelers ≥9 months old arriving from countries with risk for YF virus transmission; this includes >12-hour airport transits or layovers in countries with risk for YF virus transmission.1</td>\n",
       "      <td></td>\n",
       "      <td>All</td>\n",
       "      <td>Chloroquine</td>\n",
       "      <td>P. falciparum(primarily)\\nP. malariae,P. ovale, andP. vivax(less commonly)</td>\n",
       "      <td>Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3</td>\n",
       "      <td>October 4, 2024</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>CQ-resist</td>\n",
       "      <td>Arriving from countries with risk for YF virus transmission</td>\n",
       "      <td>Zimbabwe</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from IPython.display import display, HTML\n",
    "\n",
    "# Load DataTable for full table display\n",
    "def render_myscroll_table(df):\n",
    "    return display(HTML(df.to_html(index=False, classes=\"display nowrap\", escape=False)))\n",
    "\n",
    "# Show DataFrame\n",
    "render_myscroll_table(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
